ECG Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine 1.0.0
(1,286,567 bytes)
EGREFID | RANDID | SEX | AGE | HGHT | WGHT | SYSBP | DIABP | RACE | ETHNIC | ARMCD | VISIT | EXTRT | EXDOSE | EXDOSU | TPT | BASELINE | PCTEST | PCSTRESN | PCSTRESU | RR | PR | QT | QRS | JTPEAK | TPEAKTEND | TPEAKTPEAKP | ERD_30 | LRD_30 | Twave_amplitude | Twave_asymmetry | Twave_flatness |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
491af4aa-941a-4a89-b74c-b38d91cfc5e9 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | -0.5 | Y | NA | NA | NA | 902 | 130 | 400 | 95 | 218 | 87 | NA | 39 | 28 | 688.131 | 0.104167 | 0.363812 |
db4d09aa-f26c-4acb-92fd-6ac316918bc8 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | -0.5 | Y | NA | NA | NA | 883 | 135 | 400 | 92 | 221 | 87 | NA | 38 | 26 | 730.967 | 0.12766 | 0.365972 |
dd3caf18-354d-4c81-9ff5-6aed843cd84b | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | -0.5 | Y | NA | NA | NA | 806 | 137 | 386 | 93 | 214 | 79 | NA | 36 | 27 | 664.779 | 0.125 | 0.356294 |
12133f6e-efcf-48cc-a184-2e4d7cc05a89 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 0.5 | N | Ranolazine | 524 | ng/mL | 875 | 135 | 369 | 95 | 205 | 69 | NA | 40 | 21 | 704.884 | 0.125 | 0.350174 |
2c179592-3c18-47f2-930a-7f17ae4bc596 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 0.5 | N | Ranolazine | 524 | ng/mL | 837 | 133 | 368 | 92 | 209 | 67 | NA | 38 | 23 | 722.213 | 0.130435 | 0.340168 |
43457f03-eb84-49ef-a00a-8cbad7d5108d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 0.5 | N | Ranolazine | 524 | ng/mL | 696 | 141 | 358 | 89 | 203 | 66 | NA | 39 | 23 | 625.319 | 0.122449 | 0.333319 |
00ed2097-cd14-4f03-ab33-853da5be5550 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 1 | N | Ranolazine | 1350 | ng/mL | 808 | 133 | 377 | 95 | 205 | 77 | NA | 44 | 24 | 593.15 | 0.170213 | 0.374379 |
9d7c5729-9458-4f8f-bf32-532d6b5ee5a4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 1 | N | Ranolazine | 1350 | ng/mL | 835 | 138 | 373 | 89 | 211 | 73 | NA | 42 | 25 | 632.443 | 0.142857 | 0.378603 |
cd50da94-9c66-4b62-88a2-5879fbc17999 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 1 | N | Ranolazine | 1350 | ng/mL | 843 | 134 | 375 | 90 | 211 | 74 | NA | 42 | 25 | 650.693 | 0.163265 | 0.374338 |
3289874c-4da9-4a88-b68f-517ebacf0862 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 1.5 | N | Ranolazine | 1350 | ng/mL | 860 | 134 | 399 | 92 | 217 | 90 | NA | 39 | 29 | 682.604 | 0.125 | 0.382544 |
95dc1b28-c44a-40b1-87f2-47a00f2f99d4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 1.5 | N | Ranolazine | 1350 | ng/mL | 871 | 134 | 397 | 93 | 216 | 88 | NA | 41 | 28 | 672.454 | 0.12 | 0.399487 |
a8979e69-69d8-406d-b21b-ed30c31c84c4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 1.5 | N | Ranolazine | 1350 | ng/mL | 848 | 132 | 404 | 95 | 216 | 93 | NA | 40 | 29 | 684.772 | 0.125 | 0.378455 |
97d1bf94-e30e-45c2-8939-1c06ee5541af | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 2 | N | Ranolazine | 1220 | ng/mL | 788 | 136 | 391 | 93 | 207 | 91 | NA | 47 | 24 | 526.097 | 0.122449 | 0.372924 |
a23a2e10-d660-40de-bd4a-f2920121ebf4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 2 | N | Ranolazine | 1220 | ng/mL | 809 | 134 | 395 | 98 | 198 | 99 | NA | 40 | 31 | 539.653 | 0.102041 | 0.36004 |
f893287e-1120-4d77-b309-176c37f9b3d6 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 2 | N | Ranolazine | 1220 | ng/mL | 842 | 135 | 387 | 96 | 207 | 84 | NA | 41 | 30 | 541.47 | 0.125 | 0.38763 |
090cc59a-c3b4-4281-8224-e98fd780ba0f | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 2.5 | N | Ranolazine | 1310 | ng/mL | 734 | 134 | 385 | 97 | 200 | 88 | NA | 52 | 27 | 482.768 | 0.145833 | 0.38656 |
2e7b53b8-7c40-4c6e-8184-d052c20433de | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 2.5 | N | Ranolazine | 1310 | ng/mL | 801 | 131 | 387 | 101 | 198 | 88 | NA | 46 | 26 | 504.103 | 0.137255 | 0.377797 |
9327e8e2-5475-4fb2-82bc-9c6e66a08d50 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 2.5 | N | Ranolazine | 1310 | ng/mL | 760 | 135 | 386 | 92 | 201 | 93 | NA | 48 | 30 | 488.871 | 0.12 | 0.359138 |
2182b5dc-d37a-40f6-b0da-84e0444f0059 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 3 | N | Ranolazine | 1590 | ng/mL | 746 | 137 | 360 | 90 | 193 | 77 | NA | 44 | 25 | 490.952 | 0.115385 | 0.360869 |
b0abc36c-eca9-4378-bd7b-c363efa28e5d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 3 | N | Ranolazine | 1590 | ng/mL | 768 | 129 | 366 | 92 | 198 | 76 | NA | 42 | 28 | 517.244 | 0.122449 | 0.364242 |
d5ac7336-fc67-4fb1-8ecb-744b6881ad4d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 3 | N | Ranolazine | 1590 | ng/mL | 746 | 136 | 362 | 88 | 197 | 77 | NA | 42 | 28 | 478.827 | 0.1 | 0.357398 |
03dd2364-c8b7-4cc1-934c-da26c26375e6 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 3.5 | N | Ranolazine | 1810 | ng/mL | 796 | 127 | 359 | 91 | 200 | 68 | NA | 41 | 27 | 526.684 | 0.125 | 0.363613 |
6f6618b8-2e16-4e97-ba03-1bbb1a2594bc | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 3.5 | N | Ranolazine | 1810 | ng/mL | 801 | 133 | 358 | 92 | 195 | 71 | NA | 44 | 25 | 486.44 | 0.142857 | 0.370123 |
aa744554-5dc0-44da-982e-f7bb1de2e696 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 3.5 | N | Ranolazine | 1810 | ng/mL | 760 | 134 | 359 | 93 | 193 | 73 | NA | 41 | 27 | 464.603 | 0.0980392 | 0.353668 |
89bc17e0-d8bd-46fa-a8bf-7f2643f0a1cb | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 4 | N | Ranolazine | 2090 | ng/mL | 676 | NA | NA | NA | NA | NA | NA | 138 | 72 | 395.5 | 0.212766 | 0.361149 |
e6d8bf24-2645-4137-9e98-0bb508bf3dff | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 4 | N | Ranolazine | 2090 | ng/mL | 742 | 130 | 432 | 94 | 197 | 141 | NA | 65 | 88 | 560.647 | 0.142857 | 0.361653 |
fbd1552d-c738-4422-940f-31fcca350ac7 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 4 | N | Ranolazine | 2090 | ng/mL | 749 | 133 | 383 | 92 | 190 | 101 | NA | 35 | 35 | 563.85 | 0.142857 | 0.363976 |
2209f29c-5b9d-4854-a068-53d9e09bc2c6 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 5 | N | Ranolazine | 1770 | ng/mL | 738 | 135 | 355 | 89 | 192 | 74 | NA | 46 | 22 | 428.654 | 0.148936 | 0.326203 |
2781e113-ee22-4f9b-82be-9a012d786ab8 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 5 | N | Ranolazine | 1770 | ng/mL | 683 | 136 | 363 | 91 | 186 | 86 | NA | 49 | 24 | 387.395 | 0.125 | 0.350553 |
4eae78c3-657e-43f6-85b7-e8579c1ea4b2 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 5 | N | Ranolazine | 1770 | ng/mL | 763 | 131 | 365 | 90 | 198 | 77 | NA | 42 | 25 | 474.291 | 0.130435 | 0.337205 |
633f997a-82b4-4759-94c5-3ee49022556e | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 6 | N | Ranolazine | 1490 | ng/mL | 684 | 132 | 348 | 89 | 190 | 69 | NA | 42 | 25 | 519.806 | 0.1 | 0.32394 |
b00925df-9e0e-4ea9-a4b6-cc55afd5f9bf | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 6 | N | Ranolazine | 1490 | ng/mL | 701 | 132 | 350 | 91 | 187 | 72 | NA | 46 | 24 | 485.747 | 0.104167 | 0.332271 |
e2d15576-c3b9-47bb-9623-c43aa146e7aa | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 6 | N | Ranolazine | 1490 | ng/mL | 673 | 141 | 352 | 87 | 193 | 72 | NA | 46 | 24 | 488.159 | 0.108696 | 0.332854 |
2c476b94-1726-42dc-beac-a00ae28d611b | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 7 | N | Ranolazine | 1120 | ng/mL | 709 | 133 | 344 | 90 | 187 | 67 | NA | 41 | 24 | 559.107 | 0.102041 | 0.314435 |
7d9a1a38-5d14-43c7-9d7a-64158815a93d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 7 | N | Ranolazine | 1120 | ng/mL | 696 | 134 | 346 | 90 | 186 | 70 | NA | 44 | 22 | 560.072 | 0.106383 | 0.316145 |
e0168928-d025-4297-a6cf-f38f2e941866 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 7 | N | Ranolazine | 1120 | ng/mL | 716 | 138 | 343 | 89 | 187 | 67 | NA | 41 | 23 | 591.663 | 0.111111 | 0.307619 |
5aee9102-2bc4-4b33-bf05-f2e1533804de | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 8 | N | Ranolazine | 869 | ng/mL | 791 | 131 | 358 | 93 | 194 | 71 | NA | 42 | 26 | 589.773 | 0.14 | 0.34603 |
6b8f6cc4-afff-40d8-a100-6e5ae8e17f14 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 8 | N | Ranolazine | 869 | ng/mL | 777 | 135 | 359 | 92 | 195 | 72 | NA | 40 | 29 | 571.341 | 0.148936 | 0.353056 |
884061af-1668-4ef7-a9a1-d8512439b661 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 8 | N | Ranolazine | 869 | ng/mL | 746 | 138 | 359 | 95 | 193 | 71 | NA | 42 | 26 | 566.96 | 0.133333 | 0.338043 |
1dec654b-912a-4ae8-b2b5-da5cd6dd9484 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 12 | N | Ranolazine | 412 | ng/mL | 720 | 136 | 354 | 91 | 194 | 69 | NA | 38 | 25 | 609.073 | 0.125 | 0.341192 |
55540f2d-349b-421d-8c4f-9b7ea0e6a255 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 12 | N | Ranolazine | 412 | ng/mL | 708 | 130 | 353 | 89 | 195 | 69 | NA | 41 | 22 | 585.23 | 0.155556 | 0.327222 |
a878bc32-4456-466f-b466-a655d9cc54b1 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 12 | N | Ranolazine | 412 | ng/mL | 719 | 133 | 353 | 89 | 195 | 69 | NA | 39 | 25 | 589.806 | 0.148936 | 0.326425 |
2c1ff695-cdf3-4474-a4ce-63a8f75cb030 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 14 | N | Ranolazine | 288 | ng/mL | 760 | 138 | 354 | 96 | 191 | 67 | NA | 36 | 24 | 631.99 | 0.106383 | 0.315224 |
7b126875-8e05-43f8-8abf-3c8336a9ed19 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 14 | N | Ranolazine | 288 | ng/mL | 807 | 137 | 355 | 91 | 197 | 67 | NA | 39 | 23 | 666.469 | 0.130435 | 0.335483 |
c3169052-4ef3-4f2c-b592-154a61e549e6 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 14 | N | Ranolazine | 288 | ng/mL | 800 | 139 | 359 | 90 | 202 | 67 | NA | 38 | 25 | 667.099 | 0.12766 | 0.333999 |
35371b5f-06d8-45cd-914b-c9c978579945 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 24 | N | Ranolazine | 14.8 | ng/mL | 732 | 134 | 360 | 96 | 196 | 68 | NA | 37 | 23 | 666.795 | 0.130435 | 0.319553 |
3d42fbba-5e8e-44cd-a9f6-f7df7bf22379 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 24 | N | Ranolazine | 14.8 | ng/mL | 657 | 138 | 352 | 89 | 195 | 68 | NA | 41 | 21 | 586.664 | 0.152174 | 0.307484 |
6eed2fb6-1445-4649-a92b-7ef002b6cdf7 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-1-DOSING | Ranolazine | 1500 | mg | 24 | N | Ranolazine | 14.8 | ng/mL | 854 | 133 | 360 | 90 | 204 | 66 | NA | 38 | 23 | 729.448 | 0.0851064 | 0.325969 |
4cc3caa6-80ff-42de-a342-43fd3d4c80de | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | -0.5 | Y | NA | NA | NA | 784 | 136 | 359 | 92 | 204 | 63 | NA | 39 | 21 | 746.349 | 0.155556 | 0.318194 |
b5885c7e-6ded-4858-94ca-8eced2659605 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | -0.5 | Y | NA | NA | NA | 813 | 134 | 364 | 92 | 208 | 64 | NA | 36 | 24 | 762.162 | 0.130435 | 0.339503 |
b853e7b5-b0aa-4b9b-a985-08af1899d524 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | -0.5 | Y | NA | NA | NA | 782 | 136 | 360 | 92 | 204 | 64 | NA | 38 | 22 | 741.042 | 0.152174 | 0.317228 |
3839c4c2-e725-442e-a7cb-a974772f171b | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 0.5 | N | Verapamil | 180 | ng/mL | 692 | 157 | 339 | 91 | 181 | 67 | NA | 38 | 26 | 541.122 | 0.152174 | 0.285301 |
5336a4ee-abae-4d0f-b80b-66289e6ab2ae | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 0.5 | N | Verapamil | 180 | ng/mL | 679 | 148 | 345 | 93 | 185 | 67 | NA | 43 | 20 | 578.292 | 0.125 | 0.29852 |
a1ab42c8-6f3f-4578-96cb-d0ea60a09e3c | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 0.5 | N | Verapamil | 180 | ng/mL | 698 | 152 | 338 | 88 | 182 | 68 | NA | 40 | 24 | 540.1 | 0.136364 | 0.296525 |
2ec6b27e-604c-4ddf-8446-8f1ffa6d161b | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 1 | N | Verapamil | 188 | ng/mL | 704 | 156 | 345 | 92 | 185 | 68 | NA | 43 | 21 | 609.251 | 0.130435 | 0.293824 |
5cd5e370-85da-4d12-ac7b-b4f5872f833f | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 1 | N | Verapamil | 188 | ng/mL | 712 | 162 | 345 | 90 | 188 | 67 | NA | 38 | 25 | 632.025 | 0.106383 | 0.297059 |
7e0806d4-aaef-4687-856b-41480d983924 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 1 | N | Verapamil | 188 | ng/mL | 705 | 161 | 344 | 91 | 185 | 68 | NA | 40 | 22 | 619.108 | 0.159091 | 0.294963 |
52c29187-5a54-437a-aa3c-87f6688bee2f | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 1.5 | N | Verapamil | 156 | ng/mL | 713 | 158 | 340 | 89 | 186 | 65 | NA | 39 | 22 | 674.239 | 0.159091 | 0.29511 |
94c0d012-4cbf-48f1-b3d2-1d5c53ff90b9 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 1.5 | N | Verapamil | 156 | ng/mL | 702 | 157 | 344 | 87 | 191 | 66 | NA | 39 | 23 | 678.962 | 0.130435 | 0.303584 |
9ece0f4a-0b0c-4760-a871-82652f4075c5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 1.5 | N | Verapamil | 156 | ng/mL | 710 | 154 | 344 | 96 | 182 | 66 | NA | 40 | 21 | 677.658 | 0.125 | 0.293614 |
71612803-f327-4950-93bb-01b9ba1c4814 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 2 | N | Verapamil | 131 | ng/mL | 753 | 147 | 352 | 90 | 191 | 71 | NA | 41 | 25 | 626.975 | 0.0816327 | 0.317207 |
9a731c83-a851-40b3-a6fb-68958f862281 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 2 | N | Verapamil | 131 | ng/mL | 733 | 156 | 359 | 92 | 195 | 72 | NA | 40 | 26 | 632.35 | 0.0833333 | 0.33345 |
d593581f-d105-4142-8d8d-0dbf131ddcb5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 2 | N | Verapamil | 131 | ng/mL | 762 | 146 | 354 | 90 | 195 | 69 | NA | 41 | 24 | 624.289 | 0.106383 | 0.311593 |
0f4111f2-cc3a-473d-a7a1-e4603d49050f | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 2.5 | N | Verapamil | 94.5 | ng/mL | 764 | 140 | 355 | 92 | 192 | 71 | NA | 43 | 25 | 529.952 | 0.0869565 | 0.324093 |
eaae405a-e687-474a-b0c6-789ede98ab6a | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 2.5 | N | Verapamil | 94.5 | ng/mL | 745 | 148 | 352 | 90 | 191 | 71 | NA | 43 | 25 | 534.617 | 0.0851064 | 0.316224 |
f9053e3d-fbfb-4e86-91d1-72542f62e628 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 2.5 | N | Verapamil | 94.5 | ng/mL | 758 | 144 | 356 | 93 | 192 | 71 | NA | 43 | 24 | 557.285 | 0.0816327 | 0.313513 |
5fb763df-b4b9-4523-bf49-ac2e110922d4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 3 | N | Verapamil | 93.1 | ng/mL | 788 | 146 | 354 | 90 | 195 | 69 | NA | 43 | 22 | 597.961 | 0.104167 | 0.331107 |
cad3bc0d-46df-4718-8772-bac8cf4b9180 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 3 | N | Verapamil | 93.1 | ng/mL | 792 | 152 | 358 | 90 | 197 | 71 | NA | 42 | 24 | 598.378 | NA | NA |
fbdd09ca-7093-409d-b2db-b756f228baef | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 3 | N | Verapamil | 93.1 | ng/mL | 797 | 158 | 357 | 89 | 198 | 70 | NA | 39 | 26 | 625.959 | 0.108696 | 0.326288 |
555c2219-cc91-4143-9da6-73b450fa005e | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 3.5 | N | Verapamil | 67.1 | ng/mL | 815 | 152 | 359 | 91 | 202 | 66 | NA | 40 | 25 | 666.704 | 0.130435 | 0.327874 |
90418260-df4f-431c-94a7-3fc6cb5affcc | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 3.5 | N | Verapamil | 67.1 | ng/mL | 786 | 144 | 355 | 91 | 198 | 66 | NA | 39 | 24 | 658.881 | 0.130435 | 0.321067 |
9aa62ec1-cef1-4bcc-91a8-6acd1c62eca4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 3.5 | N | Verapamil | 67.1 | ng/mL | 830 | 144 | 358 | 90 | 202 | 66 | NA | 36 | 28 | 711.31 | 0.111111 | 0.326317 |
10873043-e02f-4ac6-8473-0af1475871f8 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 4 | N | Verapamil | 55.9 | ng/mL | 730 | 141 | 349 | 90 | 193 | 66 | NA | 38 | 23 | 641.938 | 0.130435 | 0.301048 |
3cd6891f-9ffd-4eca-bd9b-6c44b0831488 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 4 | N | Verapamil | 55.9 | ng/mL | 755 | 139 | 349 | 91 | 192 | 66 | NA | 39 | 23 | 632.378 | 0.133333 | 0.312334 |
c538452d-fe81-46fb-8c83-5f26721610aa | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 4 | N | Verapamil | 55.9 | ng/mL | 757 | 152 | 352 | 90 | 195 | 67 | NA | 39 | 23 | 639.448 | 0.113636 | 0.314072 |
46869643-a197-4cfb-9c6b-82ddfd3f7836 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 5 | N | Verapamil | 42.5 | ng/mL | 778 | 145 | 360 | 93 | 200 | 67 | NA | 38 | 24 | 704.839 | 0.133333 | 0.334817 |
946b60d9-fad8-4cdb-826b-6a4bf22a859f | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 5 | N | Verapamil | 42.5 | ng/mL | 797 | 151 | 359 | 91 | 201 | 67 | NA | 36 | 27 | 724.732 | 0.12766 | 0.331445 |
bc204d1d-ec4a-4ce8-80d5-479f1b7a872b | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 5 | N | Verapamil | 42.5 | ng/mL | 805 | 147 | 362 | 97 | 197 | 68 | NA | 37 | 26 | 728.299 | 0.12766 | 0.33329 |
30845460-af8c-4310-b13b-90a1079af336 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 6 | N | Verapamil | 25.8 | ng/mL | 742 | 139 | 346 | 90 | 189 | 67 | NA | 39 | 25 | 575.29 | 0.0888889 | 0.297309 |
5943aafd-4942-4e29-a73b-010e4176c7a7 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 6 | N | Verapamil | 25.8 | ng/mL | 718 | 140 | 351 | 91 | 192 | 68 | NA | 37 | 26 | 581.76 | 0.116279 | 0.301718 |
c5edb556-3fa8-4e4f-965b-fc1d0ac25e51 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 6 | N | Verapamil | 25.8 | ng/mL | 735 | 141 | 350 | 89 | 194 | 67 | NA | 40 | 25 | 562.9 | 0.0909091 | 0.319321 |
08c37097-a920-4ac8-8b45-f888f7cfc1df | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 7 | N | Verapamil | 19 | ng/mL | 746 | 152 | 358 | 92 | 199 | 67 | NA | 41 | 25 | 549.864 | 0.0888889 | 0.330806 |
1db78319-abc4-4128-8760-5b9907a69caa | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 7 | N | Verapamil | 19 | ng/mL | 755 | 138 | 351 | 91 | 196 | 64 | NA | 41 | 22 | 572.586 | 0.0666667 | 0.332109 |
208cbbc2-6182-438f-8afc-6eb6accb3346 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 7 | N | Verapamil | 19 | ng/mL | 755 | 138 | 356 | 89 | 202 | 65 | NA | 39 | 26 | 569.91 | 0.0909091 | 0.318572 |
0694b144-9b9d-40dd-bcf9-42f3e297523b | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 8 | N | Verapamil | 16.6 | ng/mL | 771 | 152 | 359 | 92 | 202 | 65 | NA | 39 | 27 | 560.311 | 0.111111 | 0.321937 |
22f778dc-3103-4479-83ed-fd711234ee30 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 8 | N | Verapamil | 16.6 | ng/mL | 757 | 147 | 357 | 95 | 198 | 64 | NA | 39 | 25 | 573.024 | 0.116279 | 0.328692 |
4ee910f0-eb0d-4639-8cdd-e1ff08bb1392 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 8 | N | Verapamil | 16.6 | ng/mL | 780 | 137 | 358 | 92 | 201 | 65 | NA | 41 | 25 | 556.366 | 0.111111 | 0.334778 |
0356e21d-8ff0-4fbc-979e-e7d0f5afac6a | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 12 | N | Verapamil | 9.37 | ng/mL | 713 | 150 | 344 | 92 | 185 | 67 | NA | 38 | 22 | 666.41 | 0.139535 | 0.302961 |
3b147090-5165-4d79-abf3-f001849c23a1 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 12 | N | Verapamil | 9.37 | ng/mL | 678 | 135 | 344 | 91 | 188 | 65 | NA | 38 | 22 | 640.631 | 0.139535 | 0.304006 |
596c3876-0cbc-4929-bd03-45dca957a448 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 12 | N | Verapamil | 9.37 | ng/mL | 708 | 136 | 345 | 95 | 184 | 66 | NA | 39 | 21 | 659.694 | 0.139535 | 0.290841 |
5f1d3317-c3f4-4f49-9b03-b9b220140083 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 14 | N | Verapamil | 10.3 | ng/mL | 779 | 135 | 354 | 92 | 196 | 66 | NA | 35 | 24 | 709.025 | 0.104167 | 0.309069 |
8a901108-c0bd-4208-8bfe-eb85a697caed | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 14 | N | Verapamil | 10.3 | ng/mL | 799 | 149 | 353 | 93 | 194 | 66 | NA | 37 | 23 | 714.005 | 0.136364 | 0.323477 |
c2b5c227-1ee6-49b8-8871-c8631fa70077 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 14 | N | Verapamil | 10.3 | ng/mL | 817 | 138 | 355 | 93 | 196 | 66 | NA | 36 | 24 | 725.612 | 0.136364 | 0.325995 |
761d951c-c23a-4032-bc97-725ca27ab3eb | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 24 | N | Verapamil | 4.28 | ng/mL | 762 | 145 | 350 | 94 | 190 | 66 | NA | 37 | 22 | 677.297 | 0.111111 | 0.304801 |
935a4d0e-2370-4654-a6d3-0a2762103ada | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 24 | N | Verapamil | 4.28 | ng/mL | 754 | 135 | 352 | 93 | 193 | 66 | NA | 37 | 22 | 656.815 | 0.0888889 | 0.292075 |
af73eb55-db6d-4eb5-9fbc-476f014b08eb | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-2-DOSING | Verapamil HCL | 120 | mg | 24 | N | Verapamil | 4.28 | ng/mL | 754 | 149 | 350 | 91 | 193 | 66 | NA | 39 | 22 | 646.316 | 0.0833333 | 0.300927 |
59b32384-c0f0-4595-92f7-b7f597a423b0 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | -0.5 | Y | NA | NA | NA | 836 | 134 | 370 | 92 | 212 | 66 | NA | 39 | 22 | 799.438 | 0.12766 | 0.338135 |
66a2b42a-ae22-4250-9512-33343768db54 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | -0.5 | Y | NA | NA | NA | 857 | 134 | 372 | 94 | 211 | 67 | NA | 36 | 24 | 795.902 | 0.106383 | 0.344847 |
d123bf30-f3bf-470e-8ae9-82f755112ecb | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | -0.5 | Y | NA | NA | NA | 860 | 127 | 371 | 92 | 212 | 67 | NA | 37 | 23 | 813.02 | 0.104167 | 0.332113 |
1e1788d5-e89d-48f9-afef-59411771248c | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 0.5 | N | NA | NA | NA | 955 | 127 | 381 | 93 | 219 | 69 | NA | 38 | 25 | 841.672 | 0.0816327 | 0.369124 |
c3336421-828e-489c-b096-3758b3736e67 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 0.5 | N | NA | NA | NA | 958 | 127 | 381 | 94 | 219 | 68 | NA | 38 | 24 | 868.169 | 0.106383 | 0.360165 |
c7f0d491-dbb7-4feb-8bff-a72f9c31acea | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 0.5 | N | NA | NA | NA | 991 | 127 | 382 | 93 | 220 | 69 | NA | 38 | 24 | 850.672 | 0.0816327 | 0.369667 |
59fd855d-8039-4bfa-96d0-5a838f40ba16 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 1 | N | NA | NA | NA | 825 | 126 | 367 | 90 | 210 | 67 | NA | 38 | 23 | 755.227 | 0.125 | 0.344505 |
8d6c3e9d-e969-432c-8dec-b53b15950c84 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 1 | N | NA | NA | NA | 852 | 124 | 369 | 93 | 210 | 66 | NA | 39 | 23 | 768.397 | 0.104167 | 0.339104 |
eaf58732-2704-45a4-ae84-2ae5f04b1120 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 1 | N | NA | NA | NA | 831 | 123 | 370 | 94 | 209 | 67 | NA | 37 | 24 | 767.181 | 0.104167 | 0.32548 |
0b295042-f995-44b5-a602-95118be49045 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 1.5 | N | NA | NA | NA | 810 | 126 | 366 | 93 | 206 | 67 | NA | 38 | 21 | 824.242 | 0.136364 | 0.33444 |
2b69c78c-952d-434f-9c3b-e72387eb22db | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 1.5 | N | NA | NA | NA | 852 | 130 | 367 | 91 | 209 | 67 | NA | 37 | 23 | 845.567 | 0.104167 | 0.338786 |
32f72d8d-ccda-4bdf-aea0-fc40d22b82d0 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 1.5 | N | NA | NA | NA | 870 | 127 | 371 | 92 | 211 | 68 | NA | 37 | 24 | 861.961 | 0.104167 | 0.343896 |
306981ed-63f9-41b3-abef-63ba02075cc5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 2 | N | NA | NA | NA | 881 | 131 | 379 | 92 | 218 | 69 | NA | 40 | 24 | 734.884 | 0.0612245 | 0.329794 |
7f19211f-29ad-413a-b219-306875b00eaa | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 2 | N | NA | NA | NA | 904 | 126 | 378 | 93 | 215 | 70 | NA | 37 | 26 | 770.384 | 0.06 | 0.346037 |
e7b03a3c-06a0-4c20-b82a-afc733e3f9ca | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 2 | N | NA | NA | NA | 851 | 125 | 375 | 93 | 213 | 69 | NA | 38 | 26 | 750.277 | 0.0612245 | 0.34459 |
736327d6-5f8d-4ac3-a397-c25728f70147 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 2.5 | N | NA | NA | NA | 830 | 127 | 366 | 93 | 201 | 72 | NA | 38 | 26 | 692.104 | 0.0851064 | 0.340065 |
99dddb3a-d406-407a-8522-6e24e4882f15 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 2.5 | N | NA | NA | NA | 789 | 132 | 361 | 92 | 199 | 70 | NA | 35 | 27 | 692.435 | 0.113636 | 0.330356 |
b30da0be-df99-410b-83d7-076c7563a4e3 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 2.5 | N | NA | NA | NA | 816 | 135 | 365 | 93 | 200 | 72 | NA | 38 | 24 | 683.915 | 0.108696 | 0.333178 |
9cbdfa33-6cc1-4187-ab36-9f70bc53f1f5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 3 | N | NA | NA | NA | 793 | 127 | 358 | 93 | 197 | 68 | NA | 37 | 25 | 655.357 | 0.0816327 | 0.311223 |
c0f9995c-f2f5-420e-98ef-f14a2a1ea4a4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 3 | N | NA | NA | NA | 795 | 125 | 350 | 92 | 192 | 66 | NA | 40 | 21 | 643.031 | 0.104167 | 0.300558 |
ea512a54-8f2d-4e2a-9d98-0dadd1ccec95 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 3 | N | NA | NA | NA | 776 | 126 | 357 | 93 | 197 | 67 | NA | 36 | 25 | 643.326 | NA | NA |
69c479f8-9dc9-427c-816d-64599449f4ff | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 3.5 | N | NA | NA | NA | 756 | 126 | 357 | 94 | 196 | 67 | NA | 36 | 24 | 654.647 | 0.106383 | 0.300863 |
88e7413f-ad8f-4972-a4ed-fd7eedf543d4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 3.5 | N | NA | NA | NA | 844 | 128 | 363 | 92 | 204 | 67 | NA | 35 | 25 | 726.686 | 0.0833333 | 0.312153 |
f1083a00-48e4-4084-993e-bb0701175817 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 3.5 | N | NA | NA | NA | 870 | 127 | 361 | 92 | 201 | 68 | NA | 36 | 24 | 705.772 | 0.0851064 | 0.302652 |
363b5579-8296-45d1-a1ec-59a19084195e | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 4 | N | NA | NA | NA | 792 | 125 | 355 | 92 | 196 | 67 | NA | 35 | 25 | 696.537 | NA | NA |
b496cb8c-6e15-4c11-83c3-332bfaf08c7d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 4 | N | NA | NA | NA | 783 | 126 | 354 | 90 | 197 | 67 | NA | 39 | 21 | 704.281 | 0.0888889 | 0.306596 |
bbfbe56a-7da0-407a-adb2-d109896cee1c | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 4 | N | NA | NA | NA | 762 | 123 | 357 | 94 | 198 | 65 | NA | 37 | 23 | 703.825 | 0.0833333 | 0.281794 |
6821179e-1aca-4906-8b81-f06987d4f9e5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 5 | N | NA | NA | NA | 770 | 130 | 360 | 92 | 200 | 68 | NA | 39 | 23 | 657.552 | 0.12766 | 0.331997 |
c1d43f67-6f06-4883-a303-44cad9b824bf | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 5 | N | NA | NA | NA | 786 | 128 | 361 | 93 | 200 | 68 | NA | 37 | 23 | 695.889 | 0.0869565 | 0.320721 |
f022eb1c-9a18-4f62-93a1-be832d8ddab5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 5 | N | NA | NA | NA | 796 | 127 | 362 | 93 | 202 | 67 | NA | 38 | 24 | 672.112 | 0.108696 | 0.318053 |
a01e9e26-e4c1-4b26-87b6-b22b2285e2f3 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 6 | N | NA | NA | NA | 764 | 122 | 358 | 101 | 186 | 71 | NA | 39 | 25 | 541.751 | 0.0625 | 0.298053 |
d1a012d5-e9b8-4880-b7d7-3317af561312 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 6 | N | NA | NA | NA | 699 | 127 | 351 | 90 | 193 | 68 | NA | 39 | 24 | 560.182 | 0.0666667 | 0.299169 |
f8e373d1-c0de-4a99-ad5d-434b058ab21d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 6 | N | NA | NA | NA | 780 | 124 | 356 | 92 | 195 | 69 | NA | 40 | 24 | 585.823 | 0.0652174 | 0.316455 |
137d1e28-6811-4759-b854-2a338530a858 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 7 | N | NA | NA | NA | 793 | 123 | 354 | 93 | 195 | 66 | NA | 38 | 22 | 618.999 | 0.0909091 | 0.296922 |
61559449-bae4-4adc-9fd2-5a9a056faeb8 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 7 | N | NA | NA | NA | 809 | 128 | 358 | 92 | 200 | 66 | NA | 38 | 24 | 630.607 | 0.0851064 | 0.30805 |
a0b6c3b5-f7a2-4d37-8a40-5c47fa714e0e | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 7 | N | NA | NA | NA | 706 | 134 | 349 | 91 | 194 | 64 | NA | 38 | 22 | 583.388 | 0.116279 | 0.304291 |
29bfd373-8400-4c87-9316-f0b1a1e18d01 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 8 | N | NA | NA | NA | 747 | 135 | 351 | 92 | 192 | 67 | NA | 40 | 23 | 609.601 | 0.0816327 | 0.299625 |
3381753e-6650-4da4-9958-e53fa9b68096 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 8 | N | NA | NA | NA | 777 | 134 | 352 | 91 | 194 | 67 | NA | 38 | 24 | 646.102 | 0.0816327 | 0.291201 |
a079200b-358d-4ec5-b202-c9504922c50d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 8 | N | NA | NA | NA | 713 | 133 | 352 | 97 | 187 | 68 | NA | 41 | 21 | 588.26 | 0.0888889 | 0.309309 |
8400ee60-bdce-4ea6-a092-cdd9ae2af0dd | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 12 | N | NA | NA | NA | 894 | 129 | 376 | 91 | 216 | 69 | NA | 37 | 26 | 759.894 | 0.0833333 | 0.36334 |
857e4154-6d09-421d-bac5-d88b0e6781c4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 12 | N | NA | NA | NA | 847 | 133 | 376 | 94 | 213 | 69 | NA | 38 | 24 | 735.386 | 0.122449 | 0.354502 |
c479fbc2-1e16-4d5e-b394-66a0fc620c5a | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 12 | N | NA | NA | NA | 879 | 132 | 376 | 93 | 214 | 69 | NA | 38 | 24 | 756.553 | 0.0851064 | 0.358495 |
a33115f7-3646-49b6-bd5e-d3b9e89bb768 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 14 | N | NA | NA | NA | 810 | 132 | 357 | 92 | 197 | 68 | NA | 36 | 23 | 698.822 | 0.0833333 | 0.301846 |
cccc0873-59c5-4c8b-8371-06bd37b779d4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 14 | N | NA | NA | NA | 759 | 132 | 355 | 101 | 187 | 67 | NA | 37 | 23 | 651.459 | 0.106383 | 0.303742 |
cfd87980-2204-4871-8237-a1b52016682b | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 14 | N | NA | NA | NA | 816 | 139 | 356 | 92 | 196 | 68 | NA | 38 | 23 | 694.202 | 0.0869565 | 0.298482 |
38e2df31-ae1d-40c8-96de-e8816c421a13 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 24 | N | NA | NA | NA | 696 | 123 | 351 | 91 | 196 | 64 | NA | 36 | 24 | 646.99 | 0.0909091 | 0.277968 |
61425b8c-b3e4-4162-b05b-aa51e4689e9f | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 24 | N | NA | NA | NA | 760 | 123 | 358 | 93 | 200 | 65 | NA | 36 | 23 | 707.797 | 0.0638298 | 0.283222 |
b7fce0a1-62db-41dc-b16f-855b09d962d0 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-3-DOSING | Placebo | NA | NA | 24 | N | NA | NA | NA | 726 | 127 | 351 | 92 | 195 | 64 | NA | 36 | 22 | 681.885 | 0.113636 | 0.271606 |
57c59f08-c58d-4a38-afa3-1a9233697446 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | -0.5 | Y | NA | NA | NA | 840 | 149 | 378 | 108 | 201 | 69 | NA | 39 | 24 | 658.102 | 0.130435 | 0.365239 |
5afccf3a-9a05-41c4-9f36-3768f7007130 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | -0.5 | Y | NA | NA | NA | 898 | 141 | 381 | 112 | 201 | 68 | NA | 39 | 24 | 693.738 | 0.159091 | 0.369449 |
d5604bc9-5c04-4811-9094-ae5203d1bb7f | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | -0.5 | Y | NA | NA | NA | 864 | 137 | 376 | 106 | 204 | 66 | NA | 38 | 25 | 661.72 | 0.125 | 0.359765 |
6f353a62-2cd7-41d3-93e7-04e4946c87c9 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 0.5 | N | Quinidine | 1110 | ng/mL | 905 | 130 | 403 | 97 | 229 | 77 | NA | 51 | 26 | 616.56 | 0.24 | 0.449546 |
85448cbb-2fcb-4a7f-9fd3-52d1c3dd4e04 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 0.5 | N | Quinidine | 1110 | ng/mL | 888 | 138 | 406 | 113 | 216 | 77 | NA | 51 | 27 | 623.439 | 0.244898 | 0.450875 |
a3b7fb31-80b5-437d-bf7a-ec10f7a16ca8 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 0.5 | N | Quinidine | 1110 | ng/mL | 911 | 149 | 393 | 111 | 209 | 73 | NA | 46 | 24 | 679.489 | 0.166667 | 0.421596 |
3a286725-5e94-48db-b9ae-bfb0fdd2d96e | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 1 | N | Quinidine | 1760 | ng/mL | 713 | 142 | 436 | 108 | 228 | 100 | NA | 81 | 29 | 410.398 | 0.673469 | 0.522837 |
a6a17479-f471-4fa3-a923-273d59bc8ca5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 1 | N | Quinidine | 1760 | ng/mL | 733 | 160 | 428 | 109 | 220 | 99 | NA | 77 | 31 | 419.148 | 0.693878 | 0.524072 |
fe9af0e7-0077-49e5-8149-e4ca3b9566b9 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 1 | N | Quinidine | 1760 | ng/mL | 740 | 155 | 431 | 110 | 226 | 95 | NA | 77 | 33 | 433.424 | 0.744681 | 0.532631 |
0314f793-0c07-4bd3-a53e-b0fce6c463ef | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 1.5 | N | Quinidine | 1980 | ng/mL | 778 | 146 | 439 | 101 | 230 | 108 | NA | 75 | 35 | 502.7 | 0.5 | 0.535314 |
155d22bd-b773-4bf7-a6bb-12f39b1161eb | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 1.5 | N | Quinidine | 1980 | ng/mL | 751 | 158 | 430 | 104 | 216 | 110 | NA | 58 | 49 | 472.759 | 0.44 | 0.501723 |
39e33ab8-147c-4589-b37f-7375ba9c8964 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 1.5 | N | Quinidine | 1980 | ng/mL | 773 | 152 | 436 | 104 | 228 | 104 | NA | 70 | 36 | 502.284 | 0.461538 | 0.516038 |
3266972a-25fa-45fd-b2d1-831d50c52d29 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 2 | N | Quinidine | 2070 | ng/mL | 707 | 143 | 430 | 115 | 214 | 101 | NA | 77 | 33 | 413.42 | 0.538462 | 0.508167 |
8ad48f71-ccfc-4299-9cb6-6a02b9c63225 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 2 | N | Quinidine | 2070 | ng/mL | 701 | 150 | 430 | 105 | 217 | 108 | NA | 70 | 43 | 382.075 | 0.461538 | 0.503325 |
b729e308-2e8d-4c53-8592-e6cfbace82b6 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 2 | N | Quinidine | 2070 | ng/mL | 725 | 144 | 428 | 109 | 218 | 101 | NA | 73 | 35 | 429.698 | 0.433962 | 0.501317 |
8fbcf23d-095a-4265-adea-17a276dae5b3 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 2.5 | N | Quinidine | 1940 | ng/mL | 705 | 157 | 416 | 105 | 213 | 98 | NA | 71 | 35 | 381.659 | 0.588235 | 0.50377 |
d17a4d48-2955-407a-94af-88ccb3791d00 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 2.5 | N | Quinidine | 1940 | ng/mL | 710 | 140 | 426 | 110 | 218 | 98 | NA | 76 | 32 | 379.554 | 0.54717 | 0.499326 |
fa18aab4-d005-45ee-ab00-930e3039595e | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 2.5 | N | Quinidine | 1940 | ng/mL | 701 | 147 | 422 | 103 | 223 | 96 | NA | 79 | 34 | 368.578 | 0.653061 | 0.511085 |
4b0cd557-2c71-49b4-8d37-11b03654bcd4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 3 | N | Quinidine | 1850 | ng/mL | 827 | 135 | 419 | 104 | 221 | 94 | NA | 63 | 39 | 424.904 | 0.462963 | 0.502939 |
98805ba9-2e1a-4f39-b221-7ee8c364e1e4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 3 | N | Quinidine | 1850 | ng/mL | 739 | 162 | 423 | 111 | 215 | 97 | NA | 74 | 32 | 388.218 | 0.6 | 0.504988 |
affafdcc-4cb7-451a-b79c-6accf203b37d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 3 | N | Quinidine | 1850 | ng/mL | 836 | 155 | 424 | 113 | 215 | 96 | NA | 65 | 36 | 432.519 | 0.442308 | 0.499218 |
2174f7fc-dc53-489e-a8b6-0421db356681 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 3.5 | N | Quinidine | 1980 | ng/mL | 700 | 143 | 408 | 110 | 203 | 95 | NA | 69 | 38 | 344.194 | 0.702128 | 0.486972 |
5c3742b7-fb7f-4926-a24a-920396f5a610 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 3.5 | N | Quinidine | 1980 | ng/mL | 685 | 141 | 407 | 113 | 199 | 95 | NA | 70 | 30 | 352.667 | 0.58 | 0.478712 |
8a93db7f-422d-496f-b82f-bbfa46c6a3c8 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 3.5 | N | Quinidine | 1980 | ng/mL | 663 | 146 | 399 | 100 | 206 | 93 | NA | 74 | 32 | 343.584 | 0.673469 | 0.483358 |
339d1eae-60a8-4837-9547-2a0b904f1d36 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 4 | N | Quinidine | 1850 | ng/mL | 719 | 159 | 403 | 105 | 206 | 92 | NA | 57 | 38 | 446.042 | 0.372549 | 0.457947 |
44d8072a-1b76-4317-acca-11e5fd4ec4f4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 4 | N | Quinidine | 1850 | ng/mL | 753 | 145 | 405 | 112 | 198 | 95 | NA | 66 | 29 | 427.477 | 0.333333 | 0.471334 |
6d09bcf4-9ef4-4cfe-9f0c-2c9741d318cd | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 4 | N | Quinidine | 1850 | ng/mL | 777 | 150 | 401 | 110 | 201 | 90 | NA | 64 | 29 | 451.745 | 0.320755 | 0.458715 |
8a93df3f-04a4-4712-b391-1bd68e56b9d3 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 5 | N | Quinidine | 1480 | ng/mL | 734 | 155 | 399 | 104 | 205 | 90 | NA | 55 | 38 | 463.144 | 0.392157 | 0.464645 |
91461882-3530-4134-9928-25dc8c4b6c45 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 5 | N | Quinidine | 1480 | ng/mL | 745 | 160 | 404 | 106 | 207 | 91 | NA | 64 | 27 | 474.81 | 0.352941 | 0.474825 |
e4d31b72-aefa-47ed-82cd-73af7d5dc945 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 5 | N | Quinidine | 1480 | ng/mL | 746 | 153 | 399 | 112 | 197 | 90 | NA | 59 | 32 | 470.106 | 0.346154 | 0.463168 |
110d2dbe-6d74-4658-817a-ce0f7925be8b | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 6 | N | Quinidine | 1260 | ng/mL | 713 | 146 | 399 | 101 | 206 | 92 | NA | 63 | 34 | 395.667 | 0.32 | 0.454811 |
88a407aa-0a78-4392-aae5-fc69905534fa | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 6 | N | Quinidine | 1260 | ng/mL | 692 | 139 | 397 | 105 | 198 | 94 | NA | 62 | 33 | 396.479 | 0.346939 | 0.454008 |
9cf27570-3702-487b-90a3-12399fa2192c | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 6 | N | Quinidine | 1260 | ng/mL | 680 | 142 | 397 | 105 | 198 | 94 | NA | 63 | 33 | 396.891 | 0.36 | 0.462786 |
7e1a3785-31a6-4d7e-8186-8c9afe3ec606 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 7 | N | Quinidine | 1030 | ng/mL | 846 | 137 | 407 | 97 | 224 | 86 | NA | 59 | 32 | 493.866 | 0.375 | 0.470184 |
84d489b5-48bf-4d29-a525-83c8df8fd687 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 7 | N | Quinidine | 1030 | ng/mL | 847 | 141 | 409 | 98 | 223 | 88 | NA | 56 | 36 | 499.288 | 0.361702 | 0.479314 |
a72e69fe-7bec-4c90-9468-c9cfc8e6ce7d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 7 | N | Quinidine | 1030 | ng/mL | 809 | 155 | 407 | 98 | 223 | 86 | NA | 60 | 28 | 513.085 | 0.352941 | 0.468903 |
0212cabb-f0a7-46ba-b66e-33341e2c3b01 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 8 | N | Quinidine | 1000 | ng/mL | 742 | 157 | 384 | 96 | 210 | 78 | NA | 49 | 28 | 548.698 | 0.25 | 0.410718 |
0b61746e-c5f4-4b54-8baa-4404c22e09b5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 8 | N | Quinidine | 1000 | ng/mL | 720 | 146 | 381 | 103 | 200 | 78 | NA | 50 | 27 | 539.67 | NA | NA |
e005a988-7845-4a22-889f-4471e7619080 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 8 | N | Quinidine | 1000 | ng/mL | 770 | 159 | 387 | 110 | 197 | 80 | NA | 51 | 27 | 547.984 | 0.22449 | 0.430047 |
2f1c6d98-a2ac-43c9-8927-8582033321a5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 12 | N | Quinidine | 656 | ng/mL | 764 | 146 | 386 | 97 | 212 | 77 | NA | 46 | 27 | 533.285 | 0.244444 | 0.401901 |
6db0025c-f03a-41da-9e57-0a8a5f99560e | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 12 | N | Quinidine | 656 | ng/mL | 788 | 154 | 385 | 105 | 205 | 75 | NA | 43 | 28 | 574.276 | 0.166667 | 0.403441 |
a53b0468-649d-4e7f-b400-c20484d33e27 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 12 | N | Quinidine | 656 | ng/mL | 780 | 159 | 379 | 104 | 200 | 75 | NA | 43 | 28 | 572.602 | 0.183673 | 0.402212 |
11780a98-c823-464f-acac-d23ed04a6fb2 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 14 | N | Quinidine | 525 | ng/mL | 803 | 142 | 367 | 97 | 196 | 74 | NA | 44 | 26 | 498.747 | 0.104167 | 0.357885 |
a3bfaf44-18bf-4b1c-8122-2c477d628cd4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 14 | N | Quinidine | 525 | ng/mL | 769 | 144 | 368 | 96 | 199 | 73 | NA | 43 | 27 | 512.657 | 0.166667 | 0.353827 |
b64f6439-67cf-4c3d-9e9f-718fc551273b | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 14 | N | Quinidine | 525 | ng/mL | 778 | 155 | 374 | 108 | 192 | 74 | NA | 44 | 24 | 544.263 | 0.122449 | 0.373356 |
1a1f2c9d-9a80-4496-af39-d5fde05a616a | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 24 | N | Quinidine | 194 | ng/mL | 723 | 153 | 357 | 102 | 187 | 68 | NA | 37 | 26 | 636.408 | 0.108696 | 0.324929 |
4c5b8f86-7fc7-43a9-803c-3249eb0da576 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 24 | N | Quinidine | 194 | ng/mL | 782 | 156 | 359 | 93 | 199 | 67 | NA | 40 | 23 | 671.41 | 0.106383 | 0.324746 |
f08dbee0-75e7-4d48-8ac1-842eaf035be7 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-4-DOSING | Quinidine Sulph | 400 | mg | 24 | N | Quinidine | 194 | ng/mL | 708 | 141 | 358 | 94 | 197 | 67 | NA | 41 | 23 | 615.264 | 0.104167 | 0.318644 |
49649923-6d81-42a6-abcb-57c2a8095c6d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | -0.5 | Y | NA | NA | NA | 908 | 141 | 370 | 96 | 209 | 65 | NA | 37 | 23 | 811.319 | 0.106383 | 0.338763 |
93f0a597-8412-4e5b-9e4a-54a9b995ec06 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | -0.5 | Y | NA | NA | NA | 938 | 135 | 367 | 93 | 211 | 63 | NA | 37 | 23 | 835.568 | 0.106383 | 0.343467 |
ec9f3d35-e71c-4690-9e6e-ed67ae908d5a | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | -0.5 | Y | NA | NA | NA | 901 | 143 | 372 | 100 | 207 | 65 | NA | 37 | 23 | 822.712 | 0.130435 | 0.341851 |
281d49bb-ec88-41fc-9e34-be79b9a6b865 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 0.5 | N | Dofetilide | 120 | pg/mL | 899 | 142 | 369 | 95 | 211 | 63 | NA | 36 | 24 | 844.331 | 0.106383 | 0.340283 |
78fd5554-e7f7-4c0b-ae60-33e0c7a10afe | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 0.5 | N | Dofetilide | 120 | pg/mL | 1057 | 126 | 380 | 95 | 218 | 67 | NA | 37 | 26 | 923.286 | 0.0851064 | 0.365075 |
abcc7aba-74e9-4142-af49-77a29cada3df | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 0.5 | N | Dofetilide | 120 | pg/mL | 902 | 131 | 369 | 97 | 208 | 64 | NA | 36 | 24 | 847.343 | 0.0833333 | 0.343012 |
811ecf67-2c48-488c-b0a8-bd803a989a2c | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 1 | N | Dofetilide | 1610 | pg/mL | 907 | 147 | 389 | 93 | 224 | 72 | NA | 45 | 25 | 782.433 | 0.134615 | 0.417718 |
b0c624b5-6815-4b06-9ced-d8ac58d1deb5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 1 | N | Dofetilide | 1610 | pg/mL | 949 | 139 | 392 | 94 | 225 | 73 | NA | 41 | 28 | 829.082 | 0.163265 | 0.421396 |
b976aaad-ccbd-4723-9f8a-d395d97c9502 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 1 | N | Dofetilide | 1610 | pg/mL | 979 | 144 | 395 | 96 | 225 | 74 | NA | 44 | 26 | 811.891 | 0.12 | 0.428649 |
8f690f8f-ea97-46c9-ac0c-d65256a6e1ee | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 1.5 | N | Dofetilide | 1930 | pg/mL | 896 | 158 | 425 | 92 | 245 | 88 | NA | 55 | 31 | 736.196 | 0.277778 | 0.522196 |
95c3daed-f3a8-4280-afd6-8e1f4cc1d5eb | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 1.5 | N | Dofetilide | 1930 | pg/mL | 946 | 144 | 435 | 96 | 246 | 93 | NA | 56 | 34 | 718.833 | 0.326923 | 0.531614 |
c7925cbd-aa4f-449d-afac-3edd9d958e67 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 1.5 | N | Dofetilide | 1930 | pg/mL | 958 | 138 | 436 | 95 | 250 | 91 | NA | 57 | 33 | 750.131 | 0.263158 | 0.537852 |
2a91ebdb-e318-4a5c-9ce9-3d206f95239c | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 2 | N | Dofetilide | 2430 | pg/mL | 978 | 136 | 446 | 97 | 252 | 97 | NA | 62 | 36 | 681.114 | 0.309091 | 0.541492 |
809892ba-73d6-4d61-a29a-e0ab9340b32a | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 2 | N | Dofetilide | 2430 | pg/mL | 894 | 135 | 437 | 97 | 247 | 93 | NA | 57 | 36 | 662.177 | 0.290909 | 0.531983 |
c7de2c95-5ac0-4853-a279-17254ba423c8 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 2 | N | Dofetilide | 2430 | pg/mL | 947 | 137 | 443 | 92 | 256 | 95 | NA | 64 | 34 | 665.323 | 0.296296 | 0.543672 |
7555cf1b-c4e8-4e3a-9ec1-8143dd840852 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 2.5 | N | Dofetilide | 2900 | pg/mL | 977 | 129 | 444 | 97 | 248 | 99 | NA | 64 | 35 | 626.831 | 0.407407 | 0.556854 |
a68ff78a-9570-491d-9ff1-01eeed708adf | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 2.5 | N | Dofetilide | 2900 | pg/mL | 983 | 137 | 440 | 97 | 247 | 96 | NA | 60 | 39 | 625.996 | 0.375 | 0.547357 |
c1826f9d-fadf-43ef-8425-a78ed74377c3 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 2.5 | N | Dofetilide | 2900 | pg/mL | 951 | 150 | 441 | 94 | 250 | 97 | NA | 61 | 37 | 616.966 | 0.293103 | 0.54905 |
5fcdcb68-a49d-4a01-a4ea-f1efbe8d6857 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 3 | N | Dofetilide | 2940 | pg/mL | 935 | 138 | 435 | 97 | 244 | 94 | NA | 60 | 35 | 594.777 | 0.45283 | 0.544032 |
b2f3c94b-7bb4-4648-a630-a919a104bd8c | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 3 | N | Dofetilide | 2940 | pg/mL | 888 | 139 | 434 | 96 | 243 | 95 | NA | 61 | 34 | 580.327 | 0.442308 | 0.538437 |
e2972688-ea48-420f-9cf7-964d98491423 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 3 | N | Dofetilide | 2940 | pg/mL | 929 | 146 | 431 | 96 | 241 | 94 | NA | 61 | 33 | 603.842 | 0.363636 | 0.540343 |
5110af94-46bc-47dd-9a06-b8a29728f5e8 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 3.5 | N | Dofetilide | 2500 | pg/mL | 963 | 146 | 418 | 95 | 238 | 85 | NA | 54 | 31 | 673.513 | 0.272727 | 0.505416 |
9fb1c312-9ec8-4992-bdb3-7bb6985cd335 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 3.5 | N | Dofetilide | 2500 | pg/mL | 940 | 134 | 415 | 95 | 238 | 82 | NA | 53 | 27 | 726.746 | 0.226415 | 0.49581 |
b5114b32-befb-4d51-81df-6ca9077fbb7c | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 3.5 | N | Dofetilide | 2500 | pg/mL | 937 | 147 | 417 | 98 | 235 | 84 | NA | 52 | 30 | 687.834 | 0.264151 | 0.494647 |
16e67eb7-1fb9-4b5d-a7e7-1ddf9f1b97f8 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 4 | N | Dofetilide | 2560 | pg/mL | 911 | 138 | 424 | 95 | 240 | 89 | NA | 56 | 32 | 608.64 | 0.307692 | 0.511677 |
77687f52-48c4-4fe3-bb88-56f992d57d57 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 4 | N | Dofetilide | 2560 | pg/mL | 945 | 134 | 428 | 94 | 244 | 90 | NA | 58 | 33 | 620.532 | 0.333333 | 0.521598 |
c2983217-5b53-4980-923f-f74766c2cdb2 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 4 | N | Dofetilide | 2560 | pg/mL | 918 | 134 | 426 | 97 | 240 | 89 | NA | 61 | 31 | 583.332 | 0.431373 | 0.526174 |
220a53f5-a8b0-405b-9c19-b798cef9469d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 5 | N | Dofetilide | 2120 | pg/mL | 914 | 145 | 409 | 96 | 232 | 81 | NA | 53 | 27 | 677.822 | 0.230769 | 0.484535 |
c136e5b5-19f2-4021-a665-c77987605306 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 5 | N | Dofetilide | 2120 | pg/mL | 961 | 136 | 408 | 93 | 234 | 81 | NA | 49 | 31 | 705.878 | 0.215686 | 0.480275 |
f915b8f5-252c-48da-84b8-349c52953874 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 5 | N | Dofetilide | 2120 | pg/mL | 900 | 130 | 411 | 96 | 234 | 81 | NA | 51 | 29 | 679.478 | 0.22 | 0.483896 |
644aade4-8714-41ea-9bdb-e785c9b39668 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 6 | N | Dofetilide | 1840 | pg/mL | 836 | 143 | 400 | 97 | 219 | 84 | NA | 52 | 30 | 542.646 | 0.254902 | 0.460356 |
e242025b-6616-4773-9295-25ce1ad106e4 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 6 | N | Dofetilide | 1840 | pg/mL | 830 | 138 | 403 | 96 | 223 | 84 | NA | 54 | 31 | 549.122 | 0.285714 | 0.46133 |
e5d4a42e-3e72-412b-80e3-64932478a6e2 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 6 | N | Dofetilide | 1840 | pg/mL | 859 | 141 | 403 | 98 | 223 | 82 | NA | 54 | 27 | 591.049 | 0.244898 | 0.459844 |
1fb9523a-f4e5-42c4-9c18-fb875021b709 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 7 | N | Dofetilide | 1610 | pg/mL | 948 | 131 | 406 | 97 | 228 | 81 | NA | 46 | 35 | 673.044 | 0.183673 | 0.459802 |
2a351439-0417-4c1c-a112-5a1c1bed0813 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 7 | N | Dofetilide | 1610 | pg/mL | 966 | 134 | 404 | 97 | 225 | 82 | NA | 50 | 30 | 673.718 | 0.156863 | 0.45524 |
31bccd4d-fefe-438f-9e4a-f38d676e075e | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 7 | N | Dofetilide | 1610 | pg/mL | 939 | 132 | 405 | 96 | 229 | 80 | NA | 48 | 31 | 672.484 | 0.156863 | 0.463649 |
2a0610d1-9521-464d-af2b-cac7900a254d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 8 | N | Dofetilide | 1500 | pg/mL | 890 | 131 | 385 | 93 | 216 | 76 | NA | 43 | 31 | 624.907 | 0.137255 | 0.408483 |
5c5c89a1-7c96-4955-ad30-3b0b6a479804 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 8 | N | Dofetilide | 1500 | pg/mL | 849 | 144 | 387 | 96 | 215 | 76 | NA | 41 | 31 | 646.738 | 0.16 | 0.423195 |
f1fd0035-319d-49cb-8756-7130f3cec061 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 8 | N | Dofetilide | 1500 | pg/mL | 751 | 150 | 383 | 93 | 213 | 77 | NA | 44 | 29 | 578.742 | 0.176471 | 0.413339 |
4eabf501-6dcb-418e-b751-31edc176543d | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 12 | N | Dofetilide | 874 | pg/mL | 703 | 145 | 375 | 92 | 210 | 73 | NA | 44 | 26 | 576.733 | 0.222222 | 0.399243 |
bf66cebd-f7b9-45c2-b5b5-9e1328a525e0 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 12 | N | Dofetilide | 874 | pg/mL | 813 | 150 | 380 | 93 | 214 | 73 | NA | 44 | 27 | 640.251 | 0.170213 | 0.40532 |
cda71267-4eab-4b11-881e-be12502e6033 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 12 | N | Dofetilide | 874 | pg/mL | 848 | 139 | 376 | 92 | 211 | 73 | NA | 41 | 27 | 657.774 | 0.170213 | 0.396803 |
2084cae0-27dd-46a9-99e3-76757611bfe6 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 14 | N | Dofetilide | 1090 | pg/mL | 919 | 140 | 377 | 89 | 217 | 71 | NA | 40 | 27 | 674.741 | 0.122449 | 0.392898 |
55f94ba9-7420-4e38-b449-f4cf1fdee170 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 14 | N | Dofetilide | 1090 | pg/mL | 908 | 136 | 381 | 94 | 216 | 71 | NA | 41 | 26 | 694.323 | 0.145833 | 0.37696 |
58dd3852-9118-49aa-92c3-5db6d0c2d97f | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 14 | N | Dofetilide | 1090 | pg/mL | 897 | 138 | 381 | 96 | 214 | 71 | NA | 41 | 27 | 655.954 | 0.145833 | 0.38981 |
96ef77db-f863-40e0-8ace-f775a2ed1d74 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 24 | N | Dofetilide | 261 | pg/mL | 853 | 132 | 362 | 98 | 199 | 65 | NA | 39 | 22 | 749.513 | 0.0833333 | 0.309565 |
e83ab921-cfad-41d3-9aa3-5d32ed6315d5 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 24 | N | Dofetilide | 261 | pg/mL | 854 | 147 | 359 | 96 | 198 | 65 | NA | 34 | 27 | 758.039 | 0.0888889 | 0.303375 |
f3d481cb-360b-444e-8614-80d6ffe05c90 | 1001 | F | 25 | 161.5 | 54.8 | 114.5 | 64.25 | WHITE | NOT HISPANIC OR LATINO | A,C,E,D,B | PERIOD-5-DOSING | Dofetilide | 500 | ug | 24 | N | Dofetilide | 261 | pg/mL | 782 | 127 | 358 | 97 | 195 | 66 | NA | 40 | 21 | 710.308 | 0.108696 | 0.308911 |
6f854e13-8d6f-40af-85c0-a4e802bb9c7a | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | -0.5 | Y | NA | NA | NA | 1217 | 139 | 430 | 98 | 259 | 73 | NA | 38 | 27 | 652.827 | 0.133333 | 0.328149 |
dce22bd5-2563-4e3c-8719-552c09892ec1 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | -0.5 | Y | NA | NA | NA | 1155 | 140 | 430 | 104 | 252 | 74 | NA | 39 | 27 | 649.48 | 0.139535 | 0.352886 |
ddd497db-40e3-4f7d-87b2-c5d6e0cf236c | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | -0.5 | Y | NA | NA | NA | 1208 | 157 | 427 | 99 | 256 | 72 | NA | 44 | 22 | 652.045 | 0.0833333 | 0.351518 |
12794be9-f8bc-440a-b82c-c127ed6b645f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 0.5 | N | NA | NA | NA | 1098 | 157 | 404 | 81 | 252 | 71 | NA | 38 | 25 | 650.051 | 0.108696 | 0.355498 |
8b549e2f-3d4d-4444-8636-af65aacd99ff | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 0.5 | N | NA | NA | NA | 1076 | 155 | 401 | 84 | 249 | 68 | NA | 40 | 23 | 627.614 | 0.0869565 | 0.326859 |
c3045fc3-b027-4863-aab9-202e5be1e2d2 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 0.5 | N | NA | NA | NA | 1116 | 133 | 409 | 104 | 235 | 70 | NA | 34 | 28 | 627.784 | 0.0833333 | 0.3497 |
a1202389-5985-4abf-ace5-1cb17c66da64 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 1 | N | NA | NA | NA | 1145 | 145 | 412 | 86 | 255 | 71 | NA | 40 | 25 | 619.659 | 0.0652174 | 0.382013 |
e1451048-84fb-4bed-93ef-ee39e77f236a | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 1 | N | NA | NA | NA | 1141 | 142 | 413 | 98 | 244 | 71 | NA | 39 | 24 | 625.244 | 0.106383 | 0.36015 |
f53fc9ab-3bf9-4db2-b232-81db10ffbd8b | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 1 | N | NA | NA | NA | 1157 | 139 | 414 | 98 | 243 | 73 | NA | 40 | 25 | 620.927 | 0.0851064 | 0.387318 |
16ae5a6b-4853-4a7f-b24a-bab2a48a7a46 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 1.5 | N | NA | NA | NA | 1136 | 154 | 412 | 98 | 243 | 71 | NA | 41 | 24 | 595.357 | 0.0833333 | 0.373195 |
3653b04d-2194-4dff-84b9-67adf979166c | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 1.5 | N | NA | NA | NA | 1158 | 142 | 410 | 83 | 256 | 71 | NA | 41 | 25 | 586.54 | 0.0816327 | 0.403708 |
deb0e2d2-d4d0-40ef-8ae1-93fc9f5d0d95 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 1.5 | N | NA | NA | NA | 1078 | 147 | 409 | 80 | 257 | 72 | NA | 42 | 24 | 604.987 | 0.0888889 | 0.357055 |
07f41f50-a51e-46b4-b5d5-fc1248c7706f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 2 | N | NA | NA | NA | 1044 | 154 | 404 | 98 | 234 | 72 | NA | 40 | 26 | 525.593 | 0.133333 | 0.404467 |
e483c8d1-bb45-42f9-ab99-c442a406498f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 2 | N | NA | NA | NA | 1064 | 155 | 406 | 98 | 236 | 72 | NA | 38 | 27 | 524.398 | 0.111111 | 0.402815 |
f51b1ccd-3f33-4514-ad60-661e443d62ce | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 2 | N | NA | NA | NA | 1046 | 150 | 405 | 97 | 236 | 72 | NA | 40 | 25 | 525.539 | 0.0816327 | 0.414648 |
0521bc81-ed12-4cc1-9fbc-c2699b87e083 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 2.5 | N | NA | NA | NA | 957 | 156 | 390 | 96 | 218 | 76 | NA | 39 | 27 | 433.948 | 0.0638298 | 0.396897 |
a8b41149-699d-45a2-93ea-59d1049fa25f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 2.5 | N | NA | NA | NA | 996 | 137 | 396 | 101 | 217 | 78 | NA | 40 | 30 | 425.867 | 0.0888889 | 0.403973 |
ffab8700-d707-45b8-95f2-f4dee6c537c5 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 2.5 | N | NA | NA | NA | 948 | 152 | 392 | 99 | 216 | 77 | NA | 41 | 27 | 436.517 | 0.113636 | 0.384066 |
79db186c-79a8-47ca-9f69-b7b57a5afca1 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 3 | N | NA | NA | NA | 911 | 157 | 384 | 82 | 230 | 72 | NA | 41 | 26 | 494.558 | 0.106383 | 0.374259 |
a8467fea-8241-407a-ae09-9c0b21a13f98 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 3 | N | NA | NA | NA | 858 | 155 | 380 | 81 | 227 | 72 | NA | 42 | 24 | 484.004 | NA | NA |
b9d08795-c83b-41ca-b609-dc892697f762 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 3 | N | NA | NA | NA | 788 | 157 | 373 | 103 | 200 | 70 | NA | 38 | 23 | 470.333 | 0.0930233 | 0.342598 |
1fb46a36-e5f9-4a51-9595-bd7951d76d1d | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 3.5 | N | NA | NA | NA | 855 | 131 | 374 | 97 | 208 | 69 | NA | 41 | 23 | 500.893 | 0.136364 | 0.347391 |
291a38be-6813-4b41-bd36-2fb848f1ea03 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 3.5 | N | NA | NA | NA | 848 | 147 | 376 | 94 | 210 | 72 | NA | 41 | 25 | 501.148 | 0.0930233 | 0.347991 |
ea35acda-e43a-454f-adff-fd99631f4a4c | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 3.5 | N | NA | NA | NA | 804 | 153 | 373 | 95 | 208 | 70 | NA | 43 | 22 | 502.535 | 0.136364 | 0.372061 |
7cdd2915-bea6-4f16-898d-f85cf314f934 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 4 | N | NA | NA | NA | 832 | 149 | 372 | 95 | 207 | 70 | NA | 39 | 25 | 494.824 | 0.139535 | 0.35274 |
cee46692-a3af-47c3-8d2b-2bf90fa09080 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 4 | N | NA | NA | NA | 863 | 148 | 374 | 96 | 208 | 70 | NA | 38 | 25 | 516.303 | 0.166667 | 0.359302 |
e25bdeaa-e8a8-49dd-8684-752f4194dedd | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 4 | N | NA | NA | NA | 826 | 144 | 370 | 97 | 202 | 71 | NA | 40 | 23 | 496.215 | 0.0869565 | 0.341894 |
00eba68a-8d2e-42fb-bfeb-4a1e9d7c9f67 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 5 | N | NA | NA | NA | 891 | 149 | 377 | 99 | 210 | 68 | NA | 40 | 23 | 547.182 | 0.113636 | 0.33687 |
9061f6d4-38aa-4cf4-8abf-7e117334e1e5 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 5 | N | NA | NA | NA | 855 | 152 | 377 | 100 | 208 | 69 | NA | 41 | 22 | 542.143 | 0.119048 | 0.325405 |
c5e7d34c-1df9-4a68-b45d-1e87b2f0efb6 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 5 | N | NA | NA | NA | 845 | 150 | 378 | 100 | 208 | 70 | NA | 37 | 25 | 543.044 | 0.116279 | 0.332431 |
2798b568-9b61-46f3-bf14-5cbd750c7d8f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 6 | N | NA | NA | NA | 856 | 150 | 363 | 83 | 214 | 66 | NA | 42 | 20 | 530.624 | 0.0909091 | 0.361256 |
71526268-0da0-4af9-9ab6-7c095be399d0 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 6 | N | NA | NA | NA | 852 | 154 | 365 | 99 | 198 | 68 | NA | 40 | 23 | 528.511 | 0.106383 | 0.365358 |
db1c2713-40f4-40c3-bcb7-fbcb42baa443 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 6 | N | NA | NA | NA | 840 | 146 | 361 | 100 | 194 | 67 | NA | 39 | 22 | 519.04 | 0.116279 | 0.355808 |
64b915da-dead-4aec-b172-a86f630c05d4 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 7 | N | NA | NA | NA | 940 | 157 | 375 | 99 | 207 | 69 | NA | 36 | 29 | 488.694 | 0.0652174 | 0.336861 |
e3aa23ad-73b5-40da-a6a1-90e9c4ac6a20 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 7 | N | NA | NA | NA | 929 | 151 | 371 | 96 | 206 | 69 | NA | 43 | 21 | 496.143 | 0.0851064 | 0.365701 |
ff2cee0f-6f87-40f4-ad6b-7f908840d357 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 7 | N | NA | NA | NA | 882 | 156 | 376 | 84 | 222 | 70 | NA | 43 | 23 | 501.341 | 0.0851064 | 0.361915 |
3b571d84-71eb-4747-8c17-bb386b0159cb | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 8 | N | NA | NA | NA | 890 | 155 | 382 | 82 | 228 | 72 | NA | 40 | 25 | 534.082 | 0.0930233 | 0.357388 |
97bb6a52-fefd-41d8-8ffc-20a7dd8035f4 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 8 | N | NA | NA | NA | 981 | 135 | 389 | 95 | 221 | 73 | NA | 38 | 27 | 527.296 | 0.108696 | 0.387927 |
b459c2c8-1343-48ce-998f-4b0c7e06b91d | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 8 | N | NA | NA | NA | 923 | 151 | 383 | 96 | 216 | 71 | NA | 39 | 25 | 523.223 | 0.108696 | 0.355316 |
3a5f196d-48e6-4b30-9448-51d6db5987a0 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 12 | N | NA | NA | NA | 1068 | 156 | 392 | 96 | 224 | 72 | NA | 41 | 24 | 567.773 | 0.0851064 | 0.39379 |
b7db48dc-55b4-4f3b-9c50-843cd4694729 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 12 | N | NA | NA | NA | 994 | 154 | 384 | 79 | 235 | 70 | NA | 40 | 27 | 556.886 | 0.106383 | 0.397121 |
bd9ae126-7af2-4cc3-8594-2722ea42a405 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 12 | N | NA | NA | NA | 950 | 158 | 385 | 97 | 219 | 69 | NA | 36 | 26 | 536.641 | 0.0851064 | 0.375287 |
714b0cf1-0fd1-4072-a2b1-5a03fa74cb61 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 14 | N | NA | NA | NA | 994 | 156 | 389 | 99 | 220 | 70 | NA | 40 | 22 | 567.202 | 0.0869565 | 0.375783 |
71621015-95bf-4047-a5d0-213da78471f2 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 14 | N | NA | NA | NA | 1047 | 159 | 392 | 98 | 224 | 70 | NA | 41 | 22 | 569.696 | 0.0851064 | 0.396062 |
edb984ab-ef88-45ad-81ea-9c0ff1059b39 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 14 | N | NA | NA | NA | 1013 | 162 | 386 | 99 | 216 | 71 | NA | 37 | 26 | 548.813 | 0.0816327 | 0.378451 |
9d7463e5-055a-4cc5-af32-b4bb36ee6164 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 24 | N | NA | NA | NA | 1084 | 161 | 410 | 95 | 245 | 70 | NA | 39 | 24 | 629.08 | 0.0888889 | 0.348945 |
cd99b4cc-164f-48e8-be2e-a422ccc3ff92 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 24 | N | NA | NA | NA | 1086 | 156 | 413 | 99 | 243 | 71 | NA | 37 | 25 | 622.217 | 0.0833333 | 0.357832 |
dfae6967-a431-4fd0-9634-631ce148ef58 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-1-DOSING | Placebo | NA | NA | 24 | N | NA | NA | NA | 1075 | 142 | 409 | 99 | 240 | 70 | NA | 39 | 25 | 629.514 | 0.0833333 | 0.36749 |
3e3a6d95-c7d0-4378-8f5b-49f7d473e7d3 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | -0.5 | Y | NA | NA | NA | 1104 | 125 | 415 | 90 | 255 | 70 | NA | 39 | 24 | 617.807 | 0.102041 | 0.393025 |
bb32f76d-dc70-47f8-8479-38cb4e18f4a9 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | -0.5 | Y | NA | NA | NA | 1175 | 125 | 418 | 88 | 259 | 71 | NA | 37 | 27 | 626.803 | 0.0816327 | 0.3753 |
bc3ca939-e8d5-4db1-b669-8c19156edf46 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | -0.5 | Y | NA | NA | NA | 1077 | 164 | 420 | 93 | 256 | 71 | NA | 41 | 24 | 616.899 | 0.106383 | 0.391506 |
13353232-c6bf-4606-9055-3167d92ed139 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 0.5 | N | Ranolazine | 153 | ng/mL | 1057 | 161 | 400 | 91 | 237 | 72 | NA | 38 | 25 | 638.06 | NA | NA |
a2739e66-0bda-4705-bc69-50d9d67f5fb1 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 0.5 | N | Ranolazine | 153 | ng/mL | 1104 | 140 | 394 | 91 | 234 | 69 | NA | 39 | 23 | 652.567 | 0.0425532 | 0.344747 |
f2eb468b-fbd6-4a16-a612-4ebf89167153 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 0.5 | N | Ranolazine | 153 | ng/mL | 1092 | 140 | 402 | 90 | 241 | 71 | NA | 38 | 26 | 660.39 | 0.0869565 | 0.36943 |
2ef76dc5-c746-4329-a98a-7e174c5d2e88 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 1 | N | Ranolazine | 344 | ng/mL | 1068 | 159 | 407 | 87 | 248 | 72 | NA | 39 | 26 | 617.532 | 0.06 | 0.407722 |
b616e571-badc-4ab3-91e9-81e0679cf545 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 1 | N | Ranolazine | 344 | ng/mL | 1085 | 160 | 405 | 86 | 248 | 71 | NA | 40 | 26 | 621.408 | 0.0833333 | 0.391419 |
efd19a97-34b0-4a6d-9156-40c25cbb5c7c | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 1 | N | Ranolazine | 344 | ng/mL | 1024 | 120 | 402 | 96 | 235 | 71 | NA | 38 | 27 | 609.655 | 0.106383 | 0.370089 |
7687b4d0-5370-4da2-b3eb-9d6875fbfe5b | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 1.5 | N | Ranolazine | 562 | ng/mL | 996 | 153 | 391 | 96 | 223 | 72 | NA | 44 | 22 | 601.821 | 0.125 | 0.37418 |
c027e31f-6fd5-438b-b32e-61573167b9ea | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 1.5 | N | Ranolazine | 562 | ng/mL | 958 | 145 | 390 | 87 | 232 | 71 | NA | 45 | 22 | 596.436 | 0.0833333 | 0.376604 |
e440abf0-390e-489f-a091-e4767ff59609 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 1.5 | N | Ranolazine | 562 | ng/mL | 954 | 142 | 392 | 88 | 233 | 71 | NA | 41 | 26 | 586.006 | 0.06 | 0.374463 |
23d3176e-209c-4ee8-9e2a-bcaa499acbde | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 2 | N | Ranolazine | 912 | ng/mL | 1048 | 153 | 395 | 92 | 228 | 75 | NA | 41 | 30 | 517.803 | 0.125 | 0.402042 |
e3a41c5c-be57-4393-98d4-eccbe6f6776f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 2 | N | Ranolazine | 912 | ng/mL | 949 | 159 | 392 | 94 | 225 | 73 | NA | 42 | 27 | 508.99 | 0.102041 | 0.409365 |
f7c6c7cb-e762-4f33-9425-4469b6bbaab7 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 2 | N | Ranolazine | 912 | ng/mL | 906 | 157 | 389 | 91 | 224 | 74 | NA | 43 | 26 | 484.955 | 0.108696 | 0.395614 |
0d428845-9a5a-4335-8bce-3aaa7dd2522b | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 2.5 | N | Ranolazine | 967 | ng/mL | 875 | 154 | 383 | 88 | 217 | 78 | NA | 48 | 25 | 431.272 | 0.148936 | 0.397756 |
ce0e78fc-b73d-46bd-b762-7108915ce86a | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 2.5 | N | Ranolazine | 967 | ng/mL | 867 | 158 | 380 | 87 | 217 | 76 | NA | 48 | 24 | 412.195 | 0.104167 | 0.395559 |
fcaa57ff-48e9-4839-8732-a647e3bcdf59 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 2.5 | N | Ranolazine | 967 | ng/mL | 867 | 166 | 380 | 88 | 215 | 77 | NA | 42 | 30 | 410.687 | 0.155556 | 0.391075 |
13d47e87-c4f7-4cfd-91d1-a6f12bf3b44f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 3 | N | Ranolazine | 1710 | ng/mL | 843 | 156 | 381 | 89 | 217 | 75 | NA | 49 | 23 | 467.88 | 0.125 | 0.383478 |
57311399-e46b-41d6-b43b-57283266606e | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 3 | N | Ranolazine | 1710 | ng/mL | 868 | 153 | 380 | 89 | 216 | 75 | NA | 44 | 27 | 473.89 | 0.145833 | 0.377959 |
74505d51-9cfc-4402-90bd-9665b663bbea | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 3 | N | Ranolazine | 1710 | ng/mL | 884 | 159 | 381 | 91 | 214 | 76 | NA | 46 | 26 | 468.44 | 0.12766 | 0.38799 |
422548c8-54b6-45b9-99e1-326f2b268f19 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 3.5 | N | Ranolazine | 1680 | ng/mL | 799 | 151 | 366 | 88 | 202 | 76 | NA | 51 | 23 | 419.799 | 0.155556 | 0.371682 |
7ed2b938-4090-48f6-a05a-193328de3737 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 3.5 | N | Ranolazine | 1680 | ng/mL | 782 | 150 | 370 | 87 | 205 | 78 | NA | 49 | 25 | 413.314 | 0.177778 | 0.386027 |
dd809965-4e86-45fa-a430-7fef88a064ba | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 3.5 | N | Ranolazine | 1680 | ng/mL | 772 | 149 | 363 | 86 | 202 | 75 | NA | 49 | 26 | 405.894 | 0.177778 | 0.371563 |
5a195ac8-da62-41b1-be31-c7b27e4a34d9 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 4 | N | Ranolazine | 1760 | ng/mL | 795 | 151 | 368 | 96 | 194 | 78 | NA | 48 | 24 | 399.246 | 0.183673 | 0.391577 |
626a8ed7-7784-4e01-be0a-3b2b91b85d75 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 4 | N | Ranolazine | 1760 | ng/mL | 760 | 150 | 366 | 87 | 202 | 77 | NA | 51 | 24 | 378.839 | 0.177778 | 0.383769 |
ce9efd87-329e-41f2-91fb-3283ddf7e058 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 4 | N | Ranolazine | 1760 | ng/mL | 802 | 136 | 367 | 86 | 205 | 76 | NA | 46 | 27 | 391.097 | 0.163265 | 0.392263 |
3886d817-e8b5-494d-b703-089204529a06 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 5 | N | Ranolazine | 1640 | ng/mL | 825 | 154 | 375 | 88 | 213 | 74 | NA | 45 | 29 | 441.396 | 0.130435 | 0.39486 |
b9edac2d-9c1d-4ce5-9220-b9f0cc7fcced | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 5 | N | Ranolazine | 1640 | ng/mL | 879 | 156 | 380 | 94 | 209 | 77 | NA | 47 | 26 | 459.583 | 0.173913 | 0.41681 |
c348f576-677c-46fb-94e6-93d00f65664c | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 5 | N | Ranolazine | 1640 | ng/mL | 844 | 153 | 375 | 99 | 200 | 76 | NA | 43 | 27 | 460.451 | 0.104167 | 0.403918 |
2f371d9a-270c-48e8-a1d7-16c5d4cf24ba | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 6 | N | Ranolazine | 1330 | ng/mL | 810 | 156 | 364 | 85 | 204 | 75 | NA | 50 | 22 | 436.202 | 0.183673 | 0.368903 |
c4ac7795-9092-4df9-8a15-b00f5fa0762b | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 6 | N | Ranolazine | 1330 | ng/mL | 776 | 150 | 362 | 89 | 198 | 75 | NA | 41 | 30 | 435.314 | 0.148936 | 0.3601 |
e4b9fd7d-f717-4c45-b02d-49676dc5a7fc | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 6 | N | Ranolazine | 1330 | ng/mL | 742 | 149 | 362 | 86 | 200 | 76 | NA | 44 | 28 | 409.106 | 0.173913 | 0.364539 |
07843eda-e564-4af0-be1b-c26ea42df6e8 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 7 | N | Ranolazine | 1380 | ng/mL | 831 | 151 | 382 | 97 | 207 | 78 | NA | 51 | 24 | 445.58 | 0.152174 | 0.408368 |
096e325a-904a-4cd1-8b31-e3e3a54b9d2a | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 7 | N | Ranolazine | 1380 | ng/mL | 854 | 148 | 381 | 97 | 205 | 79 | NA | 43 | 30 | 440.747 | 0.166667 | 0.404075 |
887735c6-3e65-45d8-8b42-e0be74254d58 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 7 | N | Ranolazine | 1380 | ng/mL | 888 | 155 | 381 | 95 | 208 | 78 | NA | 45 | 32 | 442.156 | 0.12766 | 0.403712 |
6079c016-7d39-42c0-8ba1-6b630e43a331 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 8 | N | Ranolazine | 1210 | ng/mL | 805 | 151 | 366 | 85 | 209 | 72 | NA | 43 | 26 | 476.601 | 0.155556 | 0.375807 |
e3a4cfe1-76e2-4c80-a021-f51d43517d58 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 8 | N | Ranolazine | 1210 | ng/mL | 833 | 149 | 367 | 87 | 208 | 72 | NA | 44 | 26 | 488.342 | 0.106383 | 0.370979 |
f43caa63-4f6d-4310-ba5c-b4bc98ca1fde | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 8 | N | Ranolazine | 1210 | ng/mL | 803 | 149 | 363 | 92 | 200 | 71 | NA | 46 | 21 | 482.608 | 0.125 | 0.368489 |
0568dd8b-6c75-4834-b878-3edaa88906e6 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 12 | N | Ranolazine | 756 | ng/mL | 962 | 167 | 387 | 87 | 225 | 75 | NA | 42 | 27 | 552.672 | 0.104167 | 0.407627 |
98e7f331-0903-4e9b-8e9f-1dc268333f20 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 12 | N | Ranolazine | 756 | ng/mL | 924 | 165 | 385 | 89 | 222 | 74 | NA | 41 | 26 | 530.304 | 0.0833333 | 0.383607 |
b1f33372-c405-4aaf-8874-3f5defd631de | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 12 | N | Ranolazine | 756 | ng/mL | 970 | 144 | 386 | 87 | 224 | 75 | NA | 41 | 26 | 546.115 | 0.0833333 | 0.387135 |
4ab04476-7e5c-45dc-906f-6b096e51616f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 14 | N | Ranolazine | 511 | ng/mL | 932 | 166 | 394 | 96 | 223 | 75 | NA | 41 | 26 | 530.905 | 0.102041 | 0.408984 |
601c4271-f45d-41b4-9681-21f85eac6d3e | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 14 | N | Ranolazine | 511 | ng/mL | 952 | 160 | 396 | 95 | 226 | 75 | NA | 42 | 26 | 521.278 | 0.104167 | 0.418842 |
942b61db-dc7a-404a-bfb3-ce97f183a2cb | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 14 | N | Ranolazine | 511 | ng/mL | 1002 | 157 | 401 | 94 | 231 | 76 | NA | 42 | 28 | 528.571 | 0.155556 | 0.411734 |
1d88dd32-4c23-4f2b-9f69-903fc600d06e | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 24 | N | Ranolazine | 147 | ng/mL | 882 | 153 | 385 | 87 | 226 | 72 | NA | 38 | 27 | 464.371 | 0.152174 | 0.383828 |
5acc1b2c-7367-41c4-8d0a-187ee09e38c6 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 24 | N | Ranolazine | 147 | ng/mL | 858 | 155 | 384 | 86 | 226 | 72 | NA | 41 | 23 | 460.22 | 0.155556 | 0.364284 |
a37c9c67-9992-4008-84b2-c4c33314dc25 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-2-DOSING | Ranolazine | 1500 | mg | 24 | N | Ranolazine | 147 | ng/mL | 927 | 158 | 382 | 86 | 223 | 73 | NA | 39 | 26 | 467.518 | NA | NA |
1c3467b5-9e16-4c78-b488-cc60e2fd90f4 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | -0.5 | Y | NA | NA | NA | 924 | 154 | 399 | 82 | 245 | 72 | NA | 45 | 22 | 541.469 | 0.145833 | 0.416731 |
645694b6-aceb-498a-93f4-f8a2bf74b782 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | -0.5 | Y | NA | NA | NA | 969 | 145 | 405 | 85 | 247 | 73 | NA | 43 | 27 | 527.492 | 0.209302 | 0.456484 |
d5f1af30-f95a-4a12-9cb6-6a1212b18823 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | -0.5 | Y | NA | NA | NA | 982 | 154 | 397 | 85 | 241 | 71 | NA | 40 | 24 | 569.299 | 0.177778 | 0.420256 |
1382230d-eaf1-4889-a085-851f0a6a81a3 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 0.5 | N | Dofetilide | 842 | pg/mL | 1018 | 154 | 395 | 80 | 245 | 70 | NA | 43 | 23 | 609.59 | 0.104167 | 0.399493 |
65b51f43-2383-4ff5-b2f1-4b17aeaea794 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 0.5 | N | Dofetilide | 842 | pg/mL | 1026 | 152 | 385 | 85 | 231 | 69 | NA | 41 | 25 | 596.95 | 0.106383 | 0.403551 |
670d0e43-6985-4480-81ce-f4b437653d43 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 0.5 | N | Dofetilide | 842 | pg/mL | 1005 | 150 | 395 | 85 | 241 | 69 | NA | 40 | 25 | 598.876 | 0.148936 | 0.392095 |
931ad1af-238f-4a57-bc8d-8d8da6f60c35 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 1 | N | Dofetilide | 1540 | pg/mL | 1088 | 152 | 428 | 92 | 257 | 79 | NA | 46 | 29 | 579.978 | 0.1875 | 0.463184 |
a8d1bc7c-11b5-44b8-88f6-0f066e9c030f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 1 | N | Dofetilide | 1540 | pg/mL | 1041 | 151 | 429 | 83 | 267 | 79 | NA | 48 | 28 | 579.476 | 0.217391 | 0.479676 |
fa070737-e885-4840-a5ec-7e161da289b7 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 1 | N | Dofetilide | 1540 | pg/mL | 1111 | 161 | 423 | 78 | 266 | 79 | NA | 47 | 27 | 591.387 | 0.16 | 0.474706 |
0273fca9-9fd6-4f14-be95-1cb9fce9aba1 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 1.5 | N | Dofetilide | 2220 | pg/mL | 889 | 154 | 415 | 80 | 256 | 79 | NA | 53 | 25 | 525.325 | 0.23913 | 0.471058 |
0cd133e5-f665-42cd-b8d6-e51513f0ff0f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 1.5 | N | Dofetilide | 2220 | pg/mL | 1002 | 155 | 421 | 79 | 261 | 81 | NA | 51 | 29 | 548.21 | 0.25 | 0.488607 |
8223cefa-aeb6-46f2-bad6-e92f6269f27f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 1.5 | N | Dofetilide | 2220 | pg/mL | 968 | 152 | 425 | 87 | 258 | 80 | NA | 47 | 31 | 566.734 | 0.191489 | 0.499604 |
d8242899-205f-4af6-a26f-1b99c6c718a7 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 2 | N | Dofetilide | 3190 | pg/mL | 900 | 156 | 442 | 93 | 259 | 90 | NA | 66 | 28 | 387.819 | 0.630435 | 0.563124 |
dca2a767-0610-4e93-a04e-fbd8b6170302 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 2 | N | Dofetilide | 3190 | pg/mL | 972 | 149 | 445 | 87 | 268 | 90 | NA | 64 | 30 | 430.368 | 0.489362 | 0.54675 |
fc76f6bb-065b-43fc-8f20-c587586d2a82 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 2 | N | Dofetilide | 3190 | pg/mL | 952 | 150 | 446 | 85 | 271 | 90 | NA | 62 | 33 | 422.738 | NA | NA |
6aaf946d-3e77-47d1-a5fb-54e718919efe | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 2.5 | N | Dofetilide | 3010 | pg/mL | 849 | 152 | 432 | 100 | 238 | 94 | NA | 60 | 38 | 331.993 | 0.615385 | 0.524593 |
95cc3e6b-e8bb-4d26-9003-1e7293c0ea61 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 2.5 | N | Dofetilide | 3010 | pg/mL | 813 | 158 | 431 | 80 | 260 | 91 | NA | 90 | 30 | 312.753 | 0.909091 | 0.53587 |
da4dc9d6-a0df-4025-b920-d1b54d264453 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 2.5 | N | Dofetilide | 3010 | pg/mL | 791 | 152 | 431 | 86 | 253 | 92 | NA | 73 | 30 | 321.103 | 0.861111 | 0.527792 |
385f7f97-6232-4dab-a811-1d673ce33aba | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 3 | N | Dofetilide | 2740 | pg/mL | 759 | 150 | 413 | 84 | 246 | 83 | NA | 70 | 29 | 321.355 | 0.604651 | 0.528327 |
b311dae7-eca0-4a22-93bd-60fa7c914642 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 3 | N | Dofetilide | 2740 | pg/mL | 823 | 150 | 418 | 82 | 248 | 88 | NA | 66 | 31 | 336.402 | 0.6 | 0.518227 |
e9d5875e-cc59-4144-b2b2-3101d1c83610 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 3 | N | Dofetilide | 2740 | pg/mL | 844 | 141 | 413 | 85 | 245 | 83 | NA | 60 | 33 | 346.983 | 0.5 | 0.522356 |
038bea7f-7ccf-42b3-b640-d0e82b7a7aa5 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 3.5 | N | Dofetilide | 2210 | pg/mL | 772 | 144 | 393 | 87 | 225 | 81 | NA | 55 | 31 | 384.894 | 0.377778 | 0.452447 |
73c84b2b-4b08-43e0-83fb-65fc85682e18 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 3.5 | N | Dofetilide | 2210 | pg/mL | 684 | 144 | 392 | 84 | 226 | 82 | NA | 66 | 27 | 337.078 | 0.714286 | 0.478713 |
9f601d8e-6a72-481d-8bb3-9913eed93127 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 3.5 | N | Dofetilide | 2210 | pg/mL | 765 | 151 | 398 | 85 | 232 | 81 | NA | 66 | 23 | 386.481 | 0.425532 | 0.462257 |
60579f3f-df1a-4efc-b5a9-f872f1ca3dd4 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 4 | N | Dofetilide | 2270 | pg/mL | 702 | 141 | 390 | 84 | 225 | 81 | NA | 66 | 29 | 327.563 | 0.738095 | 0.475497 |
c5f2519a-00a1-4878-b933-9eb39fa12b89 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 4 | N | Dofetilide | 2270 | pg/mL | 702 | 145 | 404 | 88 | 230 | 86 | NA | 60 | 36 | 332.149 | 0.944444 | 0.492284 |
d5f35ae8-03a5-43a4-a8d2-33c7a538584c | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 4 | N | Dofetilide | 2270 | pg/mL | 792 | 145 | 398 | 82 | 231 | 85 | NA | 62 | 28 | 362.135 | 0.577778 | 0.48151 |
064ba2cb-477d-4b46-acf8-cb99fea4ac64 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 5 | N | Dofetilide | 1640 | pg/mL | 746 | 147 | 398 | 85 | 231 | 82 | NA | 58 | 32 | 358.583 | 0.675676 | 0.474947 |
b203542c-7697-4866-b669-73557b4fa978 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 5 | N | Dofetilide | 1640 | pg/mL | 802 | 150 | 396 | 83 | 232 | 81 | NA | 51 | 33 | 411.737 | 0.311111 | 0.458718 |
cdef41fa-d83d-4226-8986-9732db10835d | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 5 | N | Dofetilide | 1640 | pg/mL | 809 | 148 | 404 | 85 | 235 | 84 | NA | 52 | 35 | 376.156 | 0.454545 | 0.473638 |
0331062b-725e-4bad-97ed-3c252e8ffe12 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 6 | N | Dofetilide | 1750 | pg/mL | 837 | 148 | 391 | 92 | 222 | 77 | NA | 54 | 31 | 388.849 | 0.348837 | 0.459078 |
31b1ac6a-f1b9-44a9-aa07-b7a0ca34d9bb | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 6 | N | Dofetilide | 1750 | pg/mL | 826 | 150 | 397 | 86 | 233 | 78 | NA | 57 | 28 | 390.03 | 0.255319 | 0.450972 |
81ec7bc1-a66e-4810-b9d6-3286fc7359c8 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 6 | N | Dofetilide | 1750 | pg/mL | 830 | 147 | 397 | 86 | 232 | 79 | NA | 63 | 25 | 375.827 | 0.318182 | 0.451584 |
0d36ee14-b0c5-4fa4-8c31-8a87b9f56112 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 7 | N | Dofetilide | 1510 | pg/mL | 819 | 147 | 397 | 86 | 235 | 76 | NA | 57 | 29 | 368.441 | 0.447368 | 0.447901 |
1e1283bd-ceb8-4426-aabc-4096a4e2f47e | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 7 | N | Dofetilide | 1510 | pg/mL | 842 | 146 | 399 | 86 | 236 | 77 | NA | 55 | 32 | 369.057 | 0.355556 | 0.45583 |
81505924-686d-4ca9-8bf8-8c08474799fc | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 7 | N | Dofetilide | 1510 | pg/mL | 781 | 145 | 396 | 85 | 233 | 78 | NA | 60 | 26 | 359.653 | 0.47619 | 0.465635 |
59b9047c-b719-44d0-89d9-8774563d1884 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 8 | N | Dofetilide | 1230 | pg/mL | 767 | 160 | 377 | 84 | 217 | 76 | NA | 49 | 27 | 414.668 | 0.25 | 0.405177 |
6f83d90d-a562-408d-a5f6-48976b6d490d | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 8 | N | Dofetilide | 1230 | pg/mL | 778 | 151 | 373 | 84 | 216 | 73 | NA | 47 | 27 | 434.964 | 0.195652 | 0.416487 |
bb7ebaca-23af-4c2d-9722-060eb0324277 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 8 | N | Dofetilide | 1230 | pg/mL | 761 | 151 | 371 | 83 | 215 | 73 | NA | 45 | 27 | 432.344 | 0.272727 | 0.401841 |
97f5844e-a12c-4dfa-bfd3-40c7ae323c43 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 12 | N | Dofetilide | 694 | pg/mL | 967 | 155 | 392 | 86 | 232 | 74 | NA | 38 | 29 | 530.213 | 0.145833 | 0.415709 |
bda627a3-c897-46a1-873e-91f99d98ffcf | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 12 | N | Dofetilide | 694 | pg/mL | 924 | 154 | 389 | 85 | 230 | 74 | NA | 43 | 25 | 522.17 | 0.125 | 0.440676 |
d4ad80b6-bbf0-4582-ada8-4fe3d05dbf96 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 12 | N | Dofetilide | 694 | pg/mL | 889 | 155 | 388 | 86 | 227 | 75 | NA | 40 | 28 | 509.45 | 0.148936 | 0.409854 |
0a5e2b83-7ac5-46ee-ad94-bd6db1e77655 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 14 | N | Dofetilide | 527 | pg/mL | 831 | 157 | 377 | 85 | 220 | 72 | NA | 43 | 23 | 513.566 | 0.139535 | 0.370853 |
4691d7a8-3c22-4efa-867c-abc0083770c6 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 14 | N | Dofetilide | 527 | pg/mL | 869 | 155 | 380 | 83 | 224 | 73 | NA | 43 | 22 | 491.34 | 0.108696 | 0.37939 |
eb15ca00-b591-4c70-9342-af76251fa734 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 14 | N | Dofetilide | 527 | pg/mL | 800 | 157 | 372 | 81 | 219 | 72 | NA | 40 | 25 | 465.656 | 0.173913 | 0.365786 |
418789b7-7998-45da-903a-4e4654c04670 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 24 | N | Dofetilide | 207 | pg/mL | 815 | 154 | 375 | 80 | 227 | 68 | NA | 42 | 21 | 472.85 | 0.139535 | 0.340287 |
8eab1bb7-c479-4707-a6b5-4b426dab0962 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 24 | N | Dofetilide | 207 | pg/mL | 746 | 155 | 368 | 84 | 216 | 68 | NA | 35 | 27 | 439.555 | 0.190476 | 0.331966 |
d64791ad-63c1-46d3-9f2e-6e814417a087 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-3-DOSING | Dofetilide | 500 | ug | 24 | N | Dofetilide | 207 | pg/mL | 755 | 153 | 370 | 81 | 220 | 69 | NA | 42 | 22 | 452.127 | 0.177778 | 0.366811 |
178e3931-6280-4c96-b565-00a91299adb1 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | -0.5 | Y | NA | NA | NA | 1150 | 128 | 428 | 82 | 273 | 73 | NA | 40 | 28 | 597.019 | 0.122449 | 0.413288 |
bff35005-0503-4e77-b1f1-8a82a2dbef68 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | -0.5 | Y | NA | NA | NA | 1153 | 163 | 433 | 96 | 264 | 73 | NA | 41 | 27 | 589.263 | 0.133333 | 0.413087 |
dc60f5d0-cefc-498b-bfab-cb4c6349a33f | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | -0.5 | Y | NA | NA | NA | 1151 | 157 | 432 | 85 | 274 | 73 | NA | 43 | 25 | 582.535 | 0.181818 | 0.397514 |
4f0b5258-7230-4ea7-a085-0f51640393b9 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 0.5 | N | Verapamil | 51.5 | ng/mL | 987 | 147 | 399 | 86 | 239 | 74 | NA | 48 | 23 | 482.377 | NA | NA |
83eb98a3-a5e4-4588-a163-311b3bd47f55 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 0.5 | N | Verapamil | 51.5 | ng/mL | 972 | 157 | 401 | 89 | 237 | 75 | NA | 46 | 25 | 496.703 | 0.106383 | 0.364351 |
f557d62f-fe7a-4d49-97cd-b0863b310bee | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 0.5 | N | Verapamil | 51.5 | ng/mL | 952 | 170 | 399 | 91 | 233 | 75 | NA | 44 | 25 | 486.62 | 0.106383 | 0.395158 |
81be1c58-b3be-4c23-b3a1-4ee929c13891 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 1 | N | Verapamil | 48.7 | ng/mL | 792 | 166 | 381 | 86 | 223 | 72 | NA | 42 | 24 | 448.683 | 0.173913 | 0.374686 |
bcbb3d09-45ea-4507-82cf-4ffb085dc611 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 1 | N | Verapamil | 48.7 | ng/mL | 798 | 166 | 383 | 82 | 229 | 72 | NA | 44 | 23 | 458.625 | 0.130435 | 0.363354 |
e1b2b587-b6b4-4295-8398-67d02977026a | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 1 | N | Verapamil | 48.7 | ng/mL | 935 | 169 | 393 | 81 | 239 | 73 | NA | 40 | 31 | 481.783 | 0.125 | 0.401145 |
afa3c659-8cef-4304-9ead-0f4cdad6e029 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 1.5 | N | Verapamil | 39.5 | ng/mL | 758 | 161 | 364 | 79 | 213 | 72 | NA | 46 | 23 | 467.258 | 0.125 | 0.351654 |
d62f30f2-04a0-4b4e-adb2-6ad2bb7b5296 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 1.5 | N | Verapamil | 39.5 | ng/mL | 774 | 171 | 369 | 80 | 217 | 72 | NA | 43 | 26 | 470.661 | 0.12766 | 0.352221 |
fa807592-d520-429f-b98c-8e2c9fd45f28 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 1.5 | N | Verapamil | 39.5 | ng/mL | 774 | 162 | 369 | 82 | 215 | 72 | NA | 40 | 27 | 474.633 | 0.0833333 | 0.363994 |
000c847d-a209-41dd-bb33-0575348be08e | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 2 | N | Verapamil | 25.5 | ng/mL | 794 | 160 | 372 | 81 | 218 | 73 | NA | 41 | 27 | 467.521 | 0.0869565 | 0.36263 |
77bfc426-4761-4f2d-abbd-3ccfc9a83f2d | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 2 | N | Verapamil | 25.5 | ng/mL | 788 | 164 | 367 | 85 | 211 | 71 | NA | 42 | 24 | 482.919 | 0.12766 | 0.366064 |
d919c35f-6cc7-4aef-ace2-93871db7b868 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 2 | N | Verapamil | 25.5 | ng/mL | 825 | 159 | 378 | 83 | 222 | 73 | NA | 45 | 25 | 470.871 | 0.0888889 | 0.358462 |
8ebe9dee-1af4-4e55-8835-b66225c085ab | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 2.5 | N | Verapamil | 26.3 | ng/mL | 828 | 146 | 372 | 95 | 201 | 76 | NA | 42 | 26 | 418.831 | 0.12766 | 0.345317 |
bb8b35de-60cb-41ae-b37d-7b8f307c8d07 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 2.5 | N | Verapamil | 26.3 | ng/mL | 744 | 146 | 369 | 84 | 210 | 75 | NA | 48 | 25 | 394.767 | 0.130435 | 0.353015 |
e21f44e6-6b33-44dc-95c7-9ebaaccbf765 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 2.5 | N | Verapamil | 26.3 | ng/mL | 768 | 164 | 367 | 83 | 207 | 77 | NA | 48 | 26 | 374.192 | 0.148936 | 0.350936 |
d1ee29ed-dd1e-4ec0-a21a-b5f0c20c9e7a | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 3 | N | Verapamil | 18.2 | ng/mL | 762 | 153 | 364 | 80 | 211 | 73 | NA | 46 | 24 | 427.322 | 0.12766 | 0.367432 |
e4b24261-bba9-446b-94ac-ade61eeb9fe2 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 3 | N | Verapamil | 18.2 | ng/mL | 758 | 138 | 370 | 83 | 214 | 73 | NA | 43 | 26 | 421.125 | 0.12766 | 0.362082 |
fcb4ea0c-7b69-4343-8b76-18d3b6e3bd57 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 3 | N | Verapamil | 18.2 | ng/mL | 780 | 152 | 367 | 87 | 206 | 74 | NA | 46 | 24 | 426.133 | NA | NA |
6471b943-653c-488f-bd55-384fb9324d2e | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 3.5 | N | Verapamil | 14.2 | ng/mL | 676 | 149 | 361 | 82 | 202 | 77 | NA | 46 | 27 | 380.735 | 0.130435 | 0.374074 |
de46b5aa-6444-4d82-9e12-a33d01157b85 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 3.5 | N | Verapamil | 14.2 | ng/mL | 708 | 137 | 366 | 87 | 200 | 79 | NA | 48 | 26 | 396.802 | 0.145833 | 0.382631 |
e4cd65a8-8ec9-47e7-b091-627a7f0e33ba | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 3.5 | N | Verapamil | 14.2 | ng/mL | 701 | 151 | 364 | 80 | 205 | 79 | NA | 44 | 32 | 373.51 | 0.148936 | 0.390114 |
0d7c4aac-75cd-469e-a46f-d549d8a5ce0e | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 4 | N | Verapamil | 12.6 | ng/mL | 745 | 148 | 361 | 85 | 203 | 73 | NA | 46 | 25 | 410.408 | 0.170213 | 0.389957 |
5a5132c9-2660-4291-8104-5d1331a135bf | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 4 | N | Verapamil | 12.6 | ng/mL | 749 | 137 | 366 | 86 | 208 | 72 | NA | 45 | 25 | 436.369 | 0.152174 | 0.389051 |
911cd026-2cec-405e-833a-2eb34f1f40e4 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 4 | N | Verapamil | 12.6 | ng/mL | 759 | 146 | 359 | 83 | 205 | 71 | NA | 43 | 26 | 433.353 | 0.155556 | 0.362936 |
0f69e09b-f763-4713-8f80-beed57d4b9a4 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 5 | N | Verapamil | 8.11 | ng/mL | 793 | 154 | 369 | 85 | 214 | 70 | NA | 39 | 28 | 490.79 | 0.155556 | 0.375052 |
3704f648-f287-49c8-acd3-3944387e8484 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 5 | N | Verapamil | 8.11 | ng/mL | 774 | 150 | 370 | 87 | 211 | 72 | NA | 38 | 28 | 479.034 | 0.148936 | 0.403971 |
471603b4-08d6-403e-aa9b-bdc80a97bfd5 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 5 | N | Verapamil | 8.11 | ng/mL | 756 | 151 | 363 | 82 | 211 | 70 | NA | 39 | 25 | 492.193 | 0.106383 | 0.371792 |
308776cc-8f3f-4ff3-89ae-a08cb47dd137 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 6 | N | Verapamil | 5.73 | ng/mL | 759 | 152 | 357 | 83 | 206 | 68 | NA | 43 | 23 | 465.581 | 0.116279 | 0.363833 |
68ece802-7b73-45ab-a90c-55248c24b9a1 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 6 | N | Verapamil | 5.73 | ng/mL | 766 | 152 | 357 | 84 | 204 | 69 | NA | 43 | 23 | 476.581 | 0.136364 | 0.364978 |
fb5c2a7c-b3d9-48ab-8504-4ea0778831b7 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 6 | N | Verapamil | 5.73 | ng/mL | 775 | 150 | 355 | 85 | 204 | 66 | NA | 40 | 25 | 473.9 | 0.0869565 | 0.373418 |
510df4e8-09db-4020-8089-d794109a5dcf | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 7 | N | Verapamil | 4.63 | ng/mL | 785 | 153 | 359 | 85 | 203 | 71 | NA | 38 | 26 | 538.055 | 0.12766 | 0.381451 |
5c8a399e-c19b-4c95-bfc0-ff32337e315a | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 7 | N | Verapamil | 4.63 | ng/mL | 782 | 153 | 362 | 79 | 214 | 69 | NA | 41 | 24 | 542.622 | 0.130435 | 0.368259 |
77837ff7-787a-4faa-8ff5-941f7a6d3490 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 7 | N | Verapamil | 4.63 | ng/mL | 742 | 150 | 359 | 84 | 206 | 69 | NA | 39 | 25 | 519.445 | 0.177778 | 0.371601 |
3399e331-e157-4306-8223-1b077122cf55 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 8 | N | Verapamil | 4.41 | ng/mL | 868 | 154 | 378 | 86 | 221 | 71 | NA | 40 | 25 | 555.276 | 0.108696 | 0.383152 |
3b3954a4-88dc-4319-8a46-4619b8ef9a3b | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 8 | N | Verapamil | 4.41 | ng/mL | 858 | 152 | 373 | 79 | 224 | 70 | NA | 41 | 25 | 555.432 | 0.136364 | 0.374792 |
bbd43b8a-7c70-4a34-9628-851dac17df32 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 8 | N | Verapamil | 4.41 | ng/mL | 863 | 153 | 372 | 81 | 222 | 69 | NA | 43 | 23 | 549.112 | 0.133333 | 0.388389 |
331b8e75-b9d2-47a2-aad3-cbb190520df5 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 12 | N | Verapamil | 2.57 | ng/mL | 994 | 159 | 391 | 86 | 231 | 74 | NA | 35 | 31 | 562.838 | 0.136364 | 0.408204 |
85f02fc3-6a06-4637-b0f0-7e0665a14228 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 12 | N | Verapamil | 2.57 | ng/mL | 1028 | 154 | 390 | 84 | 232 | 74 | NA | 36 | 29 | 589.552 | 0.106383 | 0.421511 |
ddeade07-3b91-46f2-8d4e-51a02fdcf18e | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 12 | N | Verapamil | 2.57 | ng/mL | 1027 | 160 | 393 | 86 | 233 | 74 | NA | 41 | 24 | 583.08 | 0.0851064 | 0.416644 |
27550ae6-e7ae-41ee-99f9-2f05565b68c0 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 14 | N | Verapamil | 2.31 | ng/mL | 1026 | 159 | 400 | 88 | 241 | 71 | NA | 38 | 25 | 673.173 | 0.111111 | 0.40823 |
cdadcbf4-55d3-4daf-aefe-1db7bc54ef74 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 14 | N | Verapamil | 2.31 | ng/mL | 1044 | 166 | 397 | 83 | 243 | 71 | NA | 37 | 26 | 671.66 | 0.106383 | 0.405744 |
d452ed0c-8055-470a-8c8f-8fefc63249c0 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 14 | N | Verapamil | 2.31 | ng/mL | 1011 | 164 | 396 | 80 | 244 | 72 | NA | 40 | 23 | 666.602 | 0.130435 | 0.403294 |
2b758e74-0169-4719-b3c0-d9d805a4c6ab | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 24 | N | Verapamil | 1.55 | ng/mL | 827 | 153 | 371 | 85 | 218 | 68 | NA | 41 | 22 | 556.397 | 0.108696 | 0.338721 |
3e6283ed-593c-4b84-b32b-d562d1a26115 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 24 | N | Verapamil | 1.55 | ng/mL | 890 | 153 | 380 | 82 | 228 | 70 | NA | 38 | 25 | 579.701 | 0.0851064 | 0.365349 |
6545d9dc-9bea-4f22-8f47-f05ce5d03bd8 | 1002 | F | 20 | 177 | 80.6 | 95.66666667 | 56 | WHITE | NOT HISPANIC OR LATINO | E,A,B,C | PERIOD-4-DOSING | Verapamil HCL | 120 | mg | 24 | N | Verapamil | 1.55 | ng/mL | 923 | 157 | 375 | 84 | 222 | 69 | NA | 41 | 23 | 576.396 | 0.0833333 | 0.366844 |
2f2d61fb-2999-4a2b-ba71-5db9d90f6590 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | -0.5 | Y | NA | NA | NA | 1300 | 193 | 428 | 100 | 257 | 71 | NA | 37 | 29 | 333.768 | 0.12766 | 0.361187 |
6f1e4b1b-154d-4e28-a240-453e322f6878 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | -0.5 | Y | NA | NA | NA | 1224 | 199 | 427 | 94 | 263 | 70 | NA | 39 | 30 | 311.949 | 0.133333 | 0.374803 |
a15c7fdd-4794-44d7-972d-5aa576b4341b | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | -0.5 | Y | NA | NA | NA | 1045 | 203 | 427 | 100 | 254 | 73 | NA | 39 | 29 | 291.886 | 0.195652 | 0.400233 |
1db6ad13-8eb3-40b0-8417-1c0f516ded06 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 0.5 | N | Dofetilide | 41.9 | pg/mL | 1286 | 207 | 420 | 97 | 258 | 65 | NA | 37 | 29 | 353.931 | 0.1 | 0.361688 |
d68a4699-938b-496a-b72e-2b7b4852eb55 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 0.5 | N | Dofetilide | 41.9 | pg/mL | 1295 | 190 | 420 | 100 | 255 | 65 | NA | 38 | 25 | 365.81 | 0.0952381 | 0.355816 |
fe3760a8-942e-40b6-9398-5da3d81872c7 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 0.5 | N | Dofetilide | 41.9 | pg/mL | 1141 | 178 | 416 | 97 | 255 | 64 | NA | 40 | 23 | 346.948 | 0.0869565 | 0.376464 |
4ac5ec10-b898-4d45-a1bd-500255bed2b7 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 1 | N | Dofetilide | 620 | pg/mL | 1246 | 188 | 432 | 97 | 264 | 71 | NA | 46 | 23 | 359.524 | 0.104167 | 0.395795 |
72476803-5098-4640-9484-7923162e56ea | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 1 | N | Dofetilide | 620 | pg/mL | 1284 | 187 | 429 | 98 | 262 | 69 | NA | 37 | 31 | 378.23 | 0.116279 | 0.400811 |
8f8bfab8-ff20-4138-947e-4cc4e537fee7 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 1 | N | Dofetilide | 620 | pg/mL | 1396 | 199 | 432 | 98 | 267 | 67 | NA | 41 | 25 | 372.117 | 0.133333 | 0.362806 |
44b9b939-cdc9-4cc9-b067-22971f70e048 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 1.5 | N | Dofetilide | 1790 | pg/mL | 1380 | 182 | 464 | 95 | 288 | 81 | NA | 51 | 30 | 373.157 | 0.156863 | 0.430257 |
91963f8d-11a8-482c-a1c2-42ef5d5ad808 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 1.5 | N | Dofetilide | 1790 | pg/mL | 1528 | 178 | 465 | 100 | 285 | 80 | NA | 49 | 30 | 349.849 | 0.195652 | 0.414901 |
f001b427-ae90-4956-b41a-6d7603bb9deb | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 1.5 | N | Dofetilide | 1790 | pg/mL | 1381 | 177 | 463 | 97 | 289 | 77 | NA | 49 | 34 | 357.365 | 0.265306 | 0.442658 |
287eee54-ba72-469f-bdbc-322088d051de | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 2 | N | Dofetilide | 2450 | pg/mL | 1198 | 162 | 464 | 97 | 288 | 79 | NA | 56 | 32 | 248.251 | 0.306122 | 0.509149 |
79765124-543e-49e8-b09f-31eb0eeab319 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 2 | N | Dofetilide | 2450 | pg/mL | 1236 | 167 | 477 | 96 | 298 | 83 | NA | 58 | 34 | 244.652 | 0.387755 | 0.51358 |
9190644e-9f30-483d-a99a-fa0a331117e3 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 2 | N | Dofetilide | 2450 | pg/mL | 1210 | 168 | 465 | 97 | 282 | 86 | NA | 53 | 35 | 243.422 | 0.26087 | 0.491652 |
1670c425-2275-4843-9172-0aa21bfd65ce | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 2.5 | N | Dofetilide | 2200 | pg/mL | 1274 | 187 | 484 | 99 | 299 | 86 | NA | 69 | 25 | 217.135 | 0.479167 | 0.515752 |
64d8b429-a163-412a-b6ce-5238d01a4c1f | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 2.5 | N | Dofetilide | 2200 | pg/mL | 1060 | 210 | 460 | 101 | 275 | 84 | NA | 56 | 38 | 215.59 | 0.5 | 0.46859 |
7fc128b6-b8c2-4240-bcbf-5769146c4806 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 2.5 | N | Dofetilide | 2200 | pg/mL | 1210 | 199 | 483 | 95 | 299 | 89 | NA | 71 | 25 | 210.029 | 0.520833 | 0.488337 |
163d0a69-f785-4750-8918-2f61e9797b1f | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 3 | N | Dofetilide | 2040 | pg/mL | 1216 | 203 | 484 | 101 | 293 | 90 | NA | 65 | 25 | 230.798 | 0.541667 | 0.503127 |
225cc162-4038-42ec-b601-a78a340333e5 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 3 | N | Dofetilide | 2040 | pg/mL | 1246 | 200 | 492 | 98 | 300 | 94 | NA | 66 | 25 | 228.015 | 0.489796 | 0.504049 |
dc019fbb-3579-4058-8711-7e7226942fb9 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 3 | N | Dofetilide | 2040 | pg/mL | 1171 | 205 | 482 | 99 | 295 | 88 | NA | 59 | 28 | 220.521 | 0.680851 | 0.508126 |
5333efe0-54a5-4d5f-a489-863a383cc7fe | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 3.5 | N | Dofetilide | 1650 | pg/mL | 1121 | 201 | 454 | 97 | 277 | 80 | NA | 52 | 35 | 268.434 | 0.456522 | 0.464728 |
8ec7ee48-d1c4-4e81-a5e9-dd46c689228b | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 3.5 | N | Dofetilide | 1650 | pg/mL | 1175 | 201 | 455 | 94 | 280 | 81 | NA | 57 | 30 | 260.797 | 0.530612 | 0.485265 |
d8da2a93-3c5e-43a8-b034-c85e19c0c505 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 3.5 | N | Dofetilide | 1650 | pg/mL | 1174 | 200 | 456 | 93 | 283 | 80 | NA | 62 | 25 | 272.381 | 0.651163 | 0.480478 |
7dd21c52-e79e-4c5b-8ec4-bfff370d7716 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 4 | N | Dofetilide | 1670 | pg/mL | 1042 | 201 | 459 | 100 | 276 | 83 | NA | 56 | 38 | 225.039 | 0.489362 | 0.487454 |
95c41588-95ea-4f77-b031-d5336a04868e | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 4 | N | Dofetilide | 1670 | pg/mL | 1092 | 201 | 458 | 98 | 272 | 88 | NA | 69 | 34 | 227.874 | 0.510638 | 0.489886 |
b119474d-a5d7-4088-9152-f9d1e4e13de2 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 4 | N | Dofetilide | 1670 | pg/mL | 1119 | 199 | 455 | 98 | 272 | 85 | NA | 59 | 37 | 233.764 | 0.555556 | 0.482404 |
0ad6fd9c-51ae-4ed2-9b09-1d1c6f863114 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 5 | N | Dofetilide | 1610 | pg/mL | 1191 | 204 | 454 | 100 | 274 | 80 | NA | 54 | 33 | 261.289 | 0.395833 | 0.43884 |
631632f5-78e9-4f38-8e7d-523d248e358b | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 5 | N | Dofetilide | 1610 | pg/mL | 1125 | 194 | 453 | 96 | 274 | 83 | NA | 51 | 31 | 279.945 | 0.361702 | 0.45533 |
cf45cf68-7af3-40cf-801d-849a18e4241e | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 5 | N | Dofetilide | 1610 | pg/mL | 1123 | 198 | 453 | 99 | 273 | 81 | NA | 53 | 33 | 250.455 | 0.434783 | 0.425372 |
4d2d26fb-af42-4be6-8916-7e4d81b0642b | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 6 | N | Dofetilide | 1320 | pg/mL | 1139 | 195 | 430 | 97 | 262 | 71 | NA | 48 | 33 | 245.077 | 0.333333 | 0.382614 |
a24ab3ef-954f-4a32-810f-a155c273309f | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 6 | N | Dofetilide | 1320 | pg/mL | 1112 | 199 | 431 | 97 | 261 | 73 | NA | 49 | 31 | 259.655 | 0.304348 | 0.379355 |
ce6e04e2-3a54-4d2a-b769-455381a5880e | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 6 | N | Dofetilide | 1320 | pg/mL | 1171 | 199 | 434 | 100 | 263 | 71 | NA | 56 | 23 | 249.273 | NA | NA |
609f7d52-845e-4f22-8a2c-c64526363763 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 7 | N | Dofetilide | 1040 | pg/mL | 1027 | 188 | 426 | 99 | 250 | 77 | NA | 54 | 31 | 281.295 | 0.395349 | 0.383288 |
8f76fa50-f441-4f63-a742-1229088acf8a | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 7 | N | Dofetilide | 1040 | pg/mL | 958 | 169 | 427 | 103 | 250 | 74 | NA | 53 | 25 | 265.564 | 0.318182 | 0.379694 |
a68bea75-d71b-4f97-b622-b4e5bf539b15 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 7 | N | Dofetilide | 1040 | pg/mL | 1067 | 193 | 424 | 99 | 251 | 74 | NA | 54 | 26 | 276.315 | 0.325581 | 0.398279 |
683fa3ec-eb38-4297-b493-07041f2f69de | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 8 | N | Dofetilide | 1470 | pg/mL | 1015 | 194 | 414 | 90 | 248 | 76 | NA | 45 | 31 | 296.977 | 0.212766 | 0.356241 |
7eab51ea-7957-4646-a5b7-b2919e003511 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 8 | N | Dofetilide | 1470 | pg/mL | 1032 | 194 | 408 | 93 | 240 | 75 | NA | 49 | 24 | 281.118 | 0.227273 | 0.3685 |
c3bb0309-e61d-400b-ab4b-5596254655fe | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 8 | N | Dofetilide | 1470 | pg/mL | 978 | 200 | 409 | 92 | 244 | 73 | NA | 47 | 27 | 277.785 | 0.295455 | 0.376926 |
58141d9c-9d17-445a-9fc0-65acd48bf24f | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 12 | N | Dofetilide | 746 | pg/mL | 1033 | 200 | 415 | 92 | 247 | 76 | NA | 45 | 26 | 322.858 | 0.282609 | 0.409749 |
5ee9b838-60e1-4e97-a39e-e569ea860698 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 12 | N | Dofetilide | 746 | pg/mL | 1072 | 198 | 412 | 95 | 243 | 74 | NA | 41 | 31 | 324.873 | 0.229167 | 0.417833 |
e8d15c33-8355-4dcf-bd9a-1ef7f108a4dd | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 12 | N | Dofetilide | 746 | pg/mL | 1038 | 197 | 406 | 97 | 236 | 73 | NA | 45 | 26 | 322.766 | 0.26087 | 0.415011 |
763853fd-8bba-41cf-878a-808069fb254e | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 14 | N | Dofetilide | 523 | pg/mL | 846 | 205 | 381 | 94 | 228 | 59 | NA | 39 | 23 | 243.52 | 0.190476 | 0.568564 |
7d1011e3-cca5-430f-bde9-801b58bb151a | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 14 | N | Dofetilide | 523 | pg/mL | 1024 | 199 | 399 | 98 | 235 | 66 | NA | 38 | 26 | 273.524 | 0.162791 | 0.421033 |
e847b97c-0305-44a1-b0b0-55ecc5f03ee8 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 14 | N | Dofetilide | 523 | pg/mL | 888 | 207 | 392 | 96 | 231 | 65 | NA | 47 | 20 | 254.416 | 0.209302 | 0.488793 |
4e4d3b2c-01ab-4c76-b242-7c6d4514b671 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 24 | N | Dofetilide | 213 | pg/mL | 981 | 161 | 404 | 96 | 237 | 71 | NA | 42 | 26 | 279.955 | 0.116279 | 0.41668 |
654e9d85-2646-477f-b4a5-13088e5a90d6 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 24 | N | Dofetilide | 213 | pg/mL | 1026 | 199 | 415 | 98 | 241 | 76 | NA | 46 | 29 | 326.27 | 0.170213 | 0.431141 |
e28cfd3a-2af5-40ac-8def-2f5d401a14c5 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-1-DOSING | Dofetilide | 500 | ug | 24 | N | Dofetilide | 213 | pg/mL | 1056 | 163 | 410 | 96 | 237 | 77 | NA | 49 | 24 | 310.309 | 0.2 | 0.424731 |
0a2f0bf2-cb55-4954-a637-427c77578b43 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | -0.5 | Y | NA | NA | NA | 862 | 207 | 382 | 91 | 219 | 72 | NA | 35 | 36 | 310.873 | 0.209302 | 0.393654 |
552d4806-0b19-4f11-b309-375a063c97ca | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | -0.5 | Y | NA | NA | NA | 932 | 179 | 387 | 96 | 220 | 71 | NA | 43 | 23 | 321.759 | 0.214286 | 0.370113 |
849350fe-1b9d-4964-95cb-62f18abfab77 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | -0.5 | Y | NA | NA | NA | 976 | 185 | 387 | 91 | 224 | 72 | NA | 41 | 27 | 326.308 | 0.162791 | 0.367646 |
3557c296-7278-49a8-b930-b8237f22e167 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 0.5 | N | NA | NA | NA | 1042 | 164 | 395 | 95 | 235 | 65 | NA | 43 | 21 | 317.771 | 0.142857 | 0.324799 |
723869b8-f29a-4ec1-ad3a-44456b379d75 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 0.5 | N | NA | NA | NA | 979 | 208 | 393 | 93 | 233 | 67 | NA | 37 | 29 | 338.546 | 0.0869565 | 0.331135 |
d0e85570-0dfe-443f-a1c4-f96d8d77fd0a | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 0.5 | N | NA | NA | NA | 1058 | 160 | 393 | 91 | 234 | 68 | NA | 45 | 22 | 313.926 | 0.142857 | 0.362275 |
0c27b1db-1b2e-49f4-8486-93294f558d26 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 1 | N | NA | NA | NA | 1110 | 183 | 400 | 92 | 240 | 68 | NA | 42 | 25 | 313.166 | 0.166667 | 0.353402 |
e2caa56b-a3b5-4b82-b454-5f5817454a1d | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 1 | N | NA | NA | NA | 1074 | 186 | 399 | 90 | 241 | 68 | NA | 45 | 24 | 311.661 | 0.139535 | 0.356451 |
ec13dd18-98c2-472b-82e9-7bdf987ecbb3 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 1 | N | NA | NA | NA | 1186 | 200 | 401 | 96 | 237 | 68 | NA | 41 | 25 | 316.135 | 0.130435 | 0.343331 |
618ef2fa-aeb7-4327-aa6f-056d2a0c11a5 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 1.5 | N | NA | NA | NA | 1224 | 175 | 413 | 92 | 250 | 71 | NA | 39 | 31 | 341.684 | 0.173913 | 0.375129 |
b4e40af1-4df7-4346-b676-ed39a19648e6 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 1.5 | N | NA | NA | NA | 1141 | 191 | 411 | 92 | 251 | 68 | NA | 37 | 34 | 340.667 | 0.155556 | 0.36476 |
bf09bdaf-eebb-420c-b8fb-588b1ebaeaad | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 1.5 | N | NA | NA | NA | 1151 | 176 | 415 | 94 | 251 | 70 | NA | 38 | 32 | 335.048 | 0.0909091 | 0.342593 |
0d7ce80c-a6bc-4a40-aa33-18c7278e7a39 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 2 | N | NA | NA | NA | 1126 | 167 | 397 | 92 | 239 | 66 | NA | 40 | 23 | 271.926 | 0.1 | 0.246278 |
93d5fc3b-03ff-4727-ad21-ecf793b36952 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 2 | N | NA | NA | NA | 991 | 167 | 393 | 92 | 237 | 64 | NA | 48 | 19 | 262.609 | 0.113636 | 0.235001 |
c6879c60-6c6e-452a-b849-8f673c477663 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 2 | N | NA | NA | NA | 1055 | 168 | 398 | 93 | 240 | 65 | NA | 41 | 23 | 265.669 | 0.121951 | 0.231024 |
4a3f3fb7-5469-45aa-b290-b41dc9a477dd | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 2.5 | N | NA | NA | NA | 906 | 210 | 380 | 94 | 219 | 67 | NA | 46 | 22 | 280.61 | 0.2 | 0.288323 |
6998f17d-d733-475e-91c8-a1fc5a7fc610 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 2.5 | N | NA | NA | NA | 880 | 204 | 378 | 93 | 217 | 68 | NA | 36 | 30 | 269.353 | 0.136364 | 0.316553 |
b208ae16-9d72-4b56-989e-16e0b4c77de8 | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 2.5 | N | NA | NA | NA | 896 | 205 | 379 | 94 | 216 | 69 | NA | 36 | 33 | 261.273 | 0.116279 | 0.309577 |
182e8673-35ad-49e8-833e-809bbefbb0fd | 1003 | F | 30 | 167 | 71.3 | 106 | 57.75 | WHITE | NOT HISPANIC OR LATINO | B,E,D,A,C | PERIOD-2-DOSING | Placebo | NA | NA | 3 | N | NA | NA | NA | 899 | 206 | 380 | 94 | 217 | 69 | NA | 38 | 30 | 263.467 | 0.133333 | 0.268681 |